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ABSTRACT 
Background: Nonsuicidal self-injury (NSSI) and NSSI disorder are common, particularly 
among adolescents and young adults, and have been associated with several adverse 
outcomes, including general psychopathology and suicide. It has been recommended to study 
self-injury separately from suicidal behaviors to better understand its etiology and 
maintaining factors. One factor that may be important to understanding NSSI is emotion 
regulation. The Difficulties in Emotion Regulation Scale (DERS) is a useful measure of the 
construct; however, for a measure to have broad research and clinical utility it must be brief.  
Despite the clinical relevance of NSSI, treatments that specifically target the behavior are 
scarce. One exception is emotion regulation group therapy (ERGT) that was developed to 
directly target NSSI and its proposed underlying mechanism of difficulties in emotion 
regulation. Although ERGT has shown promise in reducing adult NSSI and related 
difficulties it has never been evaluated under “real-world” conditions delivered by community 
clinicians, nor has it been tested in adolescents. Despite the clinical relevance, many 
individuals with NSSI never get access to empirically supported treatments. There is evidence, 
that online interventions could increase the availability of effective treatments but online 
therapy has never been evaluated for NSSI. 
Aims: The aim of the present thesis was to study clinical and psychosocial correlates and 
outcomes associated with NSSI, to develop a brief measure of emotion regulation, and to 
develop and evaluate novel treatments that can be easily and widely implemented for 
individuals who engage in NSSI.  
Methods: In Study I, we conducted a case-control study (N = 25,161) and a longitudinal 
cohort study (N = 5,370) using data from a regional clinical care register and Swedish national 
registers. We compared clinical and psychosocial correlates and subsequent adverse outcomes 
in three groups of adolescent patients who presented to child and adolescent mental health 
services with self-injury only, self-injury with suicidal ideation and behaviors, and patients 
without any indication of self-injury or suicidal ideation and behavior. In Study II, we 
developed a 16-item version of the DERS (DERS-16) and investigated its reliability and 
validity in a clinical sample (N = 96) and two community samples (Ns = 102 and 482). In 
Study III, we studied ERGT in a multi-site uncontrolled trial (N = 95). In Study IV, we 
adapted ERGT for adolescents to a novel emotion regulation individual therapy (ERITA) 
protocol that we evaluated in 17 adolescents with NSSI disorder and their parents, using an 
uncontrolled trial design. Finally, in Study V, we developed an online version of ERITA and 
included 25 adolescents with NSSI disorder and their parents in an uncontrolled pilot trial. In 
all intervention studies, measures were administered pre-treatment, post-treatment and at 6-
month follow-up. Mediation analyses were conducted in Studies IV and V.  
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Results: In Study I, results demonstrated that adolescent patients with self-injury with and 
without suicidal ideation and behavior were more burdened in terms of clinical care 
utilization, global functioning, mental disorders, and psychosocial problems than the clinical 
controls, and were at greater risk for several important adverse outcomes in emerging 
adulthood. Although the self-injury group was more burdened and at greater risk compared 
to controls, they were not as burdened as the self-injury with suicidal ideation and behavior 
group. Results from Study II showed that the shortened DERS-16 demonstrated excellent 
internal consistency, good test-retest reliability, and good convergent and discriminant 
validity. In all treatment studies (Studies III-V), treatment compliance and measures of 
credibility were acceptable, and participation in treatment was associated with significant 
reductions in NSSI and related difficulties. Moreover, change in difficulties in emotion 
regulation mediated week-to-week changes in NSSI frequency in Studies IV and V. 
Conclusions: Self-injury with and without suicidal ideation and behaviors should inform risk 
assessment and be prioritized within child and adolescent mental health services. The DERS-
16 is a valid and brief self-report measure of difficulties in emotion regulation. It is feasible to 
implement ERGT within a community-based health care system. ERITA may be a promising 
treatment for NSSI among adolescents, both in a traditional face-to-face format, and in an 
online format. Due to treatment length and format, ERGT and ERITA carry the potential to 
increase access to psychological treatments for adults and youth with NSSI. Also, in line with 
the theoretical model underlying the ERITA interventions, improvement in difficulties in 
emotion regulation mediates reduction in NSSI during treatment, thus providing further 
preliminary support for the underlying role of emotion regulation difficulties in the 
maintenance of self-destructive behaviors. 
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1 INTRODUCTION 
Nonsuicidal self-injury (NSSI) is highly prevalent and associated with suffering for the 
individual and the afflicted family. Despite the clinical relevance of this behavior, there 
remains a continued need to examine factors that maintain NSSI, the relation between NSSI 
and suicidal behavior, and outcomes associated with NSSI. Further, treatments developed 
specifically to target NSSI are scarce and most that are available have limited empirical 
support.  
My interest in NSSI and emotion regulation grew during my first years as a clinical 
psychologist at a unit specializing in dialectical behavioral therapy and borderline personality 
disorder (The Borderline Unit, Psychiatry Northwest) in Stockholm, Sweden. Individuals 
with NSSI are often misunderstood within healthcare and there are few treatment options 
available for this population. After lengthy discussions with my experienced and supporting 
mentors and colleagues, we decided to develop an early intervention for self-injurious 
behavior that carried the potential to improve psychological well-being and prevent further 
deterioration in mental health. This ambition timed well with the newly developed 
government-funded National Self-Injury Project1. Many hard-working clinicians, peer 
supporters, and researchers in this project have made these studies possible.  
This thesis describes the process of how I, together with colleagues, national and international 
collaborators, and supervisors, learned about the course of NSSI, its underlying processes, and 
developed and evaluated treatments that can be easily and widely implemented. The results 
presented are limited by design and method. However, they do point us in certain directions 
and given that this research endeavor has only just begun, I hope that it will serve as the 
foundation for a larger body of future research in this area.  
 
    Stockholm, February 2018. 
      
 
                                                        
1 A national developmental project initiated by the Swedish Ministry of Health and Social Affairs 
(Socialdepartementet) in collaboration with the Swedish Association of Local Authorities and Regions (Sveriges 
Kommuner och Landsting). Please visit https://nationellasjalvskadeprojektet.se/english/ for more information. 
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2 BACKGROUND 
2.1 NONSUICIDAL SELF-INJURY AND NONSUICIDAL SELF-INJURY 
DISORDER 
2.1.1 DEFINITION AND CLASSIFICATION 
Nonsuicidal self-injury (NSSI; also referred to as deliberate self-harm; DSH) has been defined 
as “the deliberate self-inflicted destruction of body tissue without suicidal intent and for 
purposes not socially sanctioned” [1]. Self-injury is most often inflicted with a knife, needle or 
razor and common areas for injury include the arms, legs and abdomen [2-4]. Within the 
definition of NSSI lies several important delimitations, touching on the current debate on 
how to best define self-injurious behaviors [5-8]. First, this definition does not include 
indirect and accidental self-injurious behaviors, such as disordered eating and drug abuse. 
Second, NSSI refers to the destruction of body tissue, omitting nonsuicidal self-poisoning (a 
behavior included in other definitions of self-injury [9]). Finally, the term only includes self-
injurious behaviors that were engaged in without suicidal intent. Concern has been raised 
that the distinction between non-suicidal and suicidal behaviors is difficult to make in a 
reliable manner. For example, opponents argue that underlying motivations may be unclear 
even to the individual engaging in the behavior, and, because the distinction is based on the 
individual’s own recollection, this may introduce biased and inaccurate statements [8]. 
However, there is evidence demonstrating that NSSI most often occurs without suicidal 
thoughts [10], suggesting that NSSI may be studied separate from suicide attempts. Although 
the term NSSI is debated [6,8], both clinicians and researchers have likely benefited from the 
increased clarity in terms and classifications that has emerged within the field the last few 
years [11]. 
Prior research has to a great extent focused on NSSI in the context of borderline personality 
disorder (BPD), as self-injury is one of nine diagnostic criteria of BPD [12]. However many 
individuals who engage in NSSI do not fulfill criteria for this disorder [13-15]. NSSI has 
gained increased scientific attention by itself, and was recently included on its own as a 
tentative diagnostic entity within Section 3 (“conditions for further study”) in the fifth edition 
of the Diagnostic and Statistical Manual of the American Psychiatric Association (DSM-5 
[12]). The main criteria for the proposed NSSI disorder include that NSSI has occurred on 
five or more days within the last year. Furthermore, the individual engages in the behavior 
with the expectation of either obtaining emotional or cognitive relief, to resolve an 
interpersonal difficulty, and/or creating a positive feeling state [12]. See Table 1 for the 
proposed DSM-5 criteria for NSSI disorder.  
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Table 1. Proposed criteria for Nonsuicidal Self-Injury Disorder Criteria in DSM-5 
A. In the last year, the individual has, on 5 or more days, engaged in intentional self-inflicted damage 
to the surface of his or her body of a sort likely to induce bleeding, bruising, or pain (e.g., cutting, 
buming, stabbing, hitting, excessive rubbing), with the expectation that the injury will lead to only 
minor or moderate physical harm (i.e., there is no suicidal intent). Note: The absence of suicidal 
intent has either been stated by the individual or can be inferred by the individual’s repeated 
engagement in a behavior that the individual knows, or has learned, is not likely to result in death. 
B. The individual engages in the self-injurious behavior with one or more of the following  
expectations: 
1. To obtain relief from a negative feeling or cognitive state. 
2. To resolve an interpersonal difficulty. 
3. To induce a positive feeling state. 
Note: The desired relief or response is experienced during or shortly after the selfinjury, and the 
individual may display patterns of behavior suggesting a dependence on repeatedly engaging in 
it. 
C. The intentional self-injury is associated with at least one of the following: 
1. Interpersonal difficulties or negative feelings or thoughts, such as depression, anxiety, 
tension, anger, generalized distress, or self-criticism, occurring in the period immediately prior 
to the self-injurious act. 
2. Prior to engaging in the act, a period of preoccupation with the intended behavior that is 
difficult to control. 
3. Thinking about self-injury that occurs frequently, even when it is not acted upon. 
D. The behavior is not socially sanctioned (e.g., body piercing, tattooing, part of a religious or cultural 
ritual) and is not restricted to picking a scab or nail biting. 
E. The behavior or its consequences cause clinically significant distress or interference in 
interpersonal, academic, or other important areas of functioning. 
F. The behavior does not occur exclusively during psychotic episodes, delirium, substance 
intoxication, or substance withdrawal. In individuals with a neurodevelopmental disorder, the 
behavior is not part of a pattern of repetitive stereotypies. The behavior is not better explained by 
another mental disorder or medical condition (e.g., psychotic disorder, autism spectrum disorder, 
intellectual disability, Lesch-Nyhan syndrome, stereotypic movement disorder with self-injury, 
trichotillomania [hair-pulling disorder], excoriation [skin-picking] disorder). 
Note. Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorder, Fifth 
edition, (Copyright © 2013). American Psychiatric Association. 
Given that the criteria for NSSI disorder were only recently established, most empirical 
studies in the field of NSSI, with some exceptions, have studied NSSI-behavior (later referred 
to as NSSI), not the NSSI diagnosis (later referred to as NSSI disorder). This is reflected in the 
research review below. 
2.1.2 PREVALENCE  
The average age of NSSI onset is between 13-14 years [16-18], and the behavior is common in 
both community and clinical samples. The pooled lifetime international prevalence of NSSI 
in nonclinical samples is approximately 17% among adolescents, 13% among young adults, 
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and 6% among adults [19]. NSSI is even more prevalent in clinical samples ranging from 40 
to 82% among adolescents [2,3,20,21] and 19-25% among adults [22]. The prevalence of NSSI 
disorder has been estimated to range from 1.5 to 6.7% [18,23-25] in child and adolescent 
community samples, and 0.3% in an adult community sample [26].  
A common misconception is that NSSI almost exclusively occurs among women. Although 
most research has shown that NSSI is about twice as common among adolescent females than 
adolescent males [27,28], some studies show no sex differences in prevalence for adolescents 
and young adults [19,29,30]. One meta-analysis on gender differences in the prevalence of 
NSSI concluded that NSSI is significantly more common among women than men but the 
difference was small (odds ratio [OR] = 1.5). They also found that gender differences in 
prevalence were larger for clinical samples, compared to community samples. Finally, 
although self-cutting was more common among females than males, no statistically 
significant difference was found in this study for any other method (e.g., punching [31]).  
2.1.3 CORRELATES, RISK FACTORS AND ETIOLOGY 
2.1.3.1 Diagnostic correlates 
A large majority of individuals that engage in NSSI fulfill diagnostic criteria for one or several 
psychiatric disorders [13,14,32]. Nock et al. [14] found that that 87.6% of a sample of in-
patient adolescents with NSSI met DSM-IV diagnostic criteria for at least one Axis I disorder, 
where depression, conduct disorder, and PTSD were among the most common. In this study, 
half of the sample met criteria for BPD.  
Psychiatric comorbidity has also been investigated in adolescents fulfilling diagnostic criteria 
for NSSI disorder [13,32]. For example, Glenn et al. [13] found that 73.5% also had a 
diagnosis of depression, 66.3% had an anxiety disorder and 51.7% had BPD. 
2.1.3.2 Risk factors for NSSI 
Studies of correlates and risk factors are important to better understand the etiology, predict, 
and ultimately prevent and treat a condition. The majority of studies on NSSI are cross-
sectional; however, to specify the exact nature of the association, longitudinal studies 
capturing the temporal relationship between the risk factor and outcome of interest, are 
much-needed. One of the most comprehensive meta-analysis on risk factors for NSSI 
including prospective longitudinal studies [33], concluded that few strong risk factors for the 
behavior have been identified. The strongest risk factors (ORs > 3.0) included cluster B 
personality disorders, prior history of NSSI, and hopelessness. Less strong risk factors (ORs 
near 2.0) were former suicidal thoughts/behaviors, self-reported likelihood of engaging in 
NSSI in the future, exposure to peer NSSI, and abuse. Several factors that have demonstrated 
strong associations in cross-sectional research such as emotion dysregulation and symptoms 
of depression and anxiety (e.g., [34,35]) were not meaningful predictors of NSSI in this study 
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[33]. However, in this meta-analysis the authors [33] speculate that even though these factors 
are not strong risk factors on their own, they could still contribute to the maintenance of NSSI 
engagement. Moreover, findings from this meta-analysis should be interpreted with caution 
because the strength of the associations found in the included studies in this review varied 
significantly depending on NSSI assessment method (measurement type and if NSSI was 
measured on a binary versus continuous scale), sample type, and age. Thus, after adjusting for 
publication bias in this study, the overall mean OR was rather low. Finally, these findings 
should be reviewed knowing that the included studies in the meta-analysis had a median 
follow-up period of 12 months; hence, it is possible that potential risk factors not identified in 
this study can constitute stronger risk for NSSI when studied over shorter periods of time. 
Finally, critics claim that producing a single list of the most important risk factors is a “one-
dimensional” approach that limits our understanding. It may be more meaningful to consider 
several factors together [36]. With this in mind, some of the most commonly studied 
correlates and risk factors potentially part of the etiology of the behavior are described below.  
Childhood experiences. One well-studied correlate of self-injury is childhood maltreatment, 
especially childhood sexual abuse [37]. Indeed, a recent meta-analysis found that overall 
childhood maltreatment was associated with NSSI with a medium effect size (OR = 3.42) and 
the specific association with childhood sexual abuse was OR = 2.65 [38]. Being bullied by 
peers in childhood [39] and having dysfunctional relationships [40] are other examples of 
psychological burden in adolescence that may constitute risk factors for NSSI. One review has 
proposed that social contagion (i.e., influence from friends or idols) may increase the 
likelihood that an individual engages in NSSI for the first time, however the continuation of 
NSSI is probably related to other factors [41]. There are also studies establishing a clear link 
between identification with certain youth subcultures and NSSI [42,43], with one recent 
meta-analysis demonstrating that identifying with the emo subculture is associated with 
increased risk of engaging in NSSI [43].  
Sexual orientation. In a systematic review among adolescents, Batejan et al. [44] 
demonstrated that non-heterosexual orientation (bisexual orientation in particular) is 
associated with NSSI with a medium-to-large effect size. The well-cited minority stress theory 
[45], proposes that the experience of stress (e.g., prejudice and discrimination) among sexual 
minorities may lead to adverse mental health effects and risk behaviors such as NSSI. 
2.1.3.3 Neurobiological correlates 
Most studies on neurobiological factors related to NSSI have been conducted in the context of 
adults with BPD (e.g., [46-48]); however, there are some efforts focused on studying this 
behavior independent of diagnosis (for a review, see Schreiner et al. [49]). As will be described 
in further detail later, the most common self-reported purpose of NSSI is to regulate negative 
emotions [50]. Negative affect has repeatedly been shown to be associated with cortico-limbic 
neurocircuitry [51]. Thus, this is one of the brain areas that has accumulated most of the 
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research interest in the study of circuits and physiology involved in NSSI. Below, a brief 
summary of the research field will be presented. In this section, recent research on the  
gene x environment interaction prediction of NSSI, will also be discussed. However, it is 
important to note that the field of neurobiology in NSSI is still in an early stage, thus the 
findings form single cross-sectional studies should be interpreted with caution. Further, 
without longitudinal research delineating the temporal nature, it is impossible to know if the 
biological findings are part of the cause of NSSI or if they are important correlates to 
behavioral processes such as classical and operant conditioning theorized to be involved in 
the maintenance of NSSI (described later in this thesis). 
Circuits. One study using functional magnetic resonance imaging (fMRI) found 
differentiations in the limbic system when comparing adolescents with NSSI to adolescents 
without NSSI when they processed emotional stimuli, indicating deficits in emotion 
regulation in the brain of adolescents with self-injury [52]. In line with theory and research 
on interpersonal stressful events and NSSI [3], another study using fMRI has shown 
differentiated processing of social exclusion in the medial prefrontal cortex and the 
ventrolateral prefrontal cortex, indicating that youth with NSSI may be more affected by 
social exclusion compared to those without [53].  
Because pain is inherent to NSSI, the potential rewarding effects of pain perception have been 
studied in this context. Indeed, differences during pain offset (i.e., the removal of pain) has 
been found using both self-report data as well as neuroimaging data for individuals with NSSI 
[54]. Specifically, it has been found that although adolescents and young adults with and 
without NSSI display similar levels of pain in response to pain stimuli, the NSSI group report 
greater levels of pain relief after withdrawal from the pain stimuli. This relief was correlated 
with blood oxygen level dependent signal within the dorsal striatum, an area that has been 
tied to reward circuitry [54]. Research on relief from pain has shown that the removal of 
physical pain simultaneously simulates positive affect and diminishes negative affect, which 
may be part of the reinforcing consequences of NSSI. Indeed, the cerebrospinal fluid levels of 
endogenous opioids, that are related to pain perception, has been shown to be different in 
individuals with NSSI compared to clinical controls. Specifically, B-endorphin and met-
enkephalin levels were significantly lower for the NSSI group, providing evidence for the 
involvement of endogenous opioid system in NSSI [55]. However, in lack of longitudinal 
studies any conclusions regarding causality are precluded.  
Physiology. As many individuals with NSSI report that they engage in the behavior in 
response to stress [56], several studies have focused on the hypothalamic-pituitary 
adrenocortical (HPA) axis. This is an area known to be involved in the coping of stressful 
situations [57-59]. Further, early life adversity, prevalent in individuals with NSSI, is 
associated with HPA axis dysregulation possibly via epigenetic mechanisms (for a review see 
[60]). Indeed, individuals with NSSI have been shown to have a heightened cortisol 
awakening response [57], an efficient negative feedback loop [58], and hyporesponsiveness of 
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the HPA axis in acutely stressful situations [59]. Further, worth noting is that HPA axis 
dysregulation has also been reported in several studies of suicide attempters and suicide 
victims [61]. 
Genes. There is limited research in this area; however, an interaction between gene and 
environment in relation to NSSI has been found. One study indicated that short carriers of 
the Serotonin Transporter-linked Polymorphic Region (5-HTTLPR) who experienced 
chronic interpersonal stress had the highest level of NSSI engagement [62].  
2.1.4 COURSE AND SUBSEQUENT OUTCOMES  
In a recent systematic review of the course of NSSI (also including some studies with self-
injury with unclear suicidal intent), Plener et al. [63] found that in longitudinal studies 
among adolescents, the trend was that rates of NSSI increased over time. However, in studies 
of older adolescents and young adults, there was a trend for rates to decrease during follow-
up. The authors concluded that peak prevalence of NSSI is found during adolescence at 
around 15 to 17 years of age and that remission is expected for most in young to middle 
adulthood. However, it is important to note that although many individuals cease the 
behavior within a few years, it does have a more chronic course for some [4]. Further, Plener 
et al. [63] raised the concern that even if individuals cease with repetitive NSSI they may still 
be at risk of using other maladaptive emotion regulation strategies. Indeed, one recent study 
has demonstrated that teenagers with previous NSSI are more likely to show high levels of 
substance misuse [64].  
Little is known about the subsequent outcomes associated with NSSI, as most studies have not 
differentiated between nonsuicidal and suicidal self-injury. However, in one of the few 
exceptions, Mars et al. [65] demonstrated that adolescents with NSSI had elevated risks of 
developing a range of mental problems (including depression and anxiety disorders) at age 16 
years, recurrent episode of self-injury, and problem substance misuse, emphasizing the need 
for early identification and treatment of youth who engage in NSSI. Few long-term follow-up 
studies exist (and to my knowledge none on NSSI). However, one recent study followed 
adolescents with self-injurious behaviors for approximately 15 years and found a wide range 
of psychosocial problems at follow-up, including mental health problems, illicit drug use, and 
unemployment. Yet, it is important to note that most associations attenuated after controlling 
for adolescent mental disorders [66]. I am not aware of any longitudinal studies that have 
studied the course of NSSI disorder. 
2.1.4.1 Suicide 
As previously discussed, the relation between self-injury without suicidal intent and actual 
suicide attempts is a complex issue. Even though NSSI per definition is performed without 
suicidal intent and seldom co-occurs with suicidal thoughts [10], several studies indicate that 
NSSI is a risk factor for later suicide attempt and completed suicide. Longitudinal findings 
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have shown that NSSI predicts suicide attempts even after controlling for a history of suicidal 
behavior [67-69]. These findings indicate that early effective interventions for those who 
engage in NSSI could potentially have a suicide preventive effect.  
2.1.5 THEORETICAL MODELS OF NSSI 
NSSI was once regarded as an unusual marginal component of psychiatric populations or 
developmentally disabled cohorts, but it may be better understood as a relatively common 
way for individuals to manage emotional pain and to cope with interpersonal difficulties [70]. 
NSSI can serve a multitude of functions for individuals engaging in these behaviors. As 
reflected in the DSM-5 criteria for NSSI disorder [12], the different functions of NSSI can be 
divided into two categories: intrapersonal (i.e., relief from aversive affective and/or cognitive 
state) and interpersonal (e.g., relief from social demands). The most commonly reported 
functions of NSSI are intrapersonal [50]. This intrapersonal function is largely driven by 
difficulties in emotion regulation [71,72].  
The two most cited theoretical models specifically developed for NSSI is Chapman et al’s [71] 
experiential avoidance model (EAM) of NSSI and Nock’s [73] integrated theoretical model 
of the development and maintenance of NSSI. Both models use a functional perspective to 
describe the maintenance of NSSI. 
2.1.5.1 The experiential avoidance model of NSSI 
Chapman et al. [71] have proposed the EAM model of NSSI, which is based on behavioral 
theory. This model emphasizes difficulties in emotion regulation, and poses that NSSI is 
primarily maintained through negative reinforcement in the form of avoidance of aversive 
emotional experiences. In contrast to previous models of self-injury, which have focused 
more specifically on certain populations (e.g., individuals with BPD [72]), the EAM was 
developed to describe the maintenance of NSSI across different populations. As illustrated in 
Figure 1, the EAM proposes that NSSI is maintained by escape conditioning and negative 
reinforcement. The model describes how a stimulus triggers an unwanted emotional 
response, and the individual experiences an urge to avoid this experience. Due to low 
availability of more adaptive responses, the individual engages in NSSI, which reduces the 
emotional arousal, thus negatively reinforcing the behavior. Through repetition of negative 
reinforcement, the association between unwanted emotional arousal and NSSI is 
strengthened, and as a result, NSSI becomes an automatic escape response. Chapman et al. 
[71] argue that although NSSI likely has several determinants, the role of experiential 
avoidance in NSSI is well-established in the literature and is helpful to understand the 
maintenance of the behavior.  
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Figure 1. Graphic depiction of the Experiential Avoidance Model (EAM) of deliberate self-harm  
(DSH). In: Chapman, A. L., Gratz, K. L., & Brown, M. Z. (2006). Solving the puzzle of deliberate  
self-harm: The experiential avoidance model. Behaviour Research and Therapy, 44, 371-394. 
Reprinted with permission from Elsevier. 
2.1.5.2 The integrated theoretical model of the development and maintenance of 
NSSI 
Nock [73] adopts an integrated perspective, including findings from different areas of 
research. According to his model, distal risk factors (such as genetic predisposition for 
emotional/cognitive reactivity and childhood abuse) make the individual vulnerable 
through deficits in distress tolerance and interpersonal skills, which in interaction with 
NSSI-specific vulnerability factors (e.g., social learning, self-punishment) lead the 
individual to engage in NSSI in response to stressful events instead of using more adaptive 
strategies. NSSI is then maintained because of its short-term effectiveness in regulating 
aversive emotional experiences and social situations [73].  
2.1.6 STIGMA 
Growing awareness of the high prevalence of NSSI among adolescents has provided school 
and health care services with new challenges. NSSI causes great concern among staff in 
various settings [74] and individuals who engage in NSSI often report negative responses 
from professionals [75]. Although NSSI is a serious condition, many individuals who engage 
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in self-injury never seek help [76-78] or tell others about the behavior [79]. The stigma and 
shame associated with NSSI [80] is probably an important barrier to treatment-seeking [81]. 
2.2 EMOTION REGULATION  
2.2.1 DEFINITION 
Interest and empirical research on emotion regulation has increased rapidly over the past two 
decades [82]. According to Thompson [83, pp. 27-28], emotion regulation refers to “extrinsic 
and intrinsic processes responsible for monitoring, evaluating, and modifying emotional 
reactions, especially their intensive and temporal features, to accomplish one's goals”. 
However, emotion regulation has been defined in several ways, with some conceptualizations 
emphasizing the ability to control emotional experience, expression, and reduction of 
emotional arousal [84,85]. In contrast, other conceptualizations of emotion regulation 
emphasize that all emotions are functional [86-88]. Inherent in these latter conceptualizations 
of emotion regulation, is the concept that emotions are functional because they provide 
information about ourselves, our environment, and motivate behaviors that may facilitate 
situationally appropriate behaviors [89]. This implies that difficulties in the awareness, 
understanding, or modulation of emotions may interfere with adaptation to situational 
demands and contribute to various unwanted outcomes. A steady increasing body of research 
offers empirical support for emotion regulation deficits as an underlying mechanism in a 
wide range of psychopathology and risky behaviors (for a review, see Sheppes et al. [90]), 
including NSSI [34].  
2.2.2 ASSESSMENT OF EMOTION REGULATION  
Given the obvious clinical relevance of emotion regulation, several questionnaires have been 
developed, designed to measure different aspects of the construct (e.g., [91-95]). One of the 
most well-established measures of emotion regulation is the Difficulties in Emotion 
Regulation Scale (DERS [96]). The DERS is a 36-item self-report measure that assesses 
different aspects of difficulties in emotion regulation. The DERS was developed to be a 
clinically useful instrument based on the latter conceptualization described above. 
Specifically, the DERS aims to measure the: “(a) awareness, understanding, and acceptance of 
emotions; (b) ability to engage in goal-directed behaviors and inhibit impulsive behaviors 
when experiencing negative emotions; (c) flexible use of situationally-appropriate strategies to 
modulate the intensity and/or duration of emotional responses, rather than to eliminate 
emotions entirely; and (d) willingness to experience negative emotions as part of pursuing 
meaningful activities in life” [87, p. 1094].  
2.3 TREATMENTS SPECIFIC TO NSSI  
To date, treatments specifically designed to target NSSI are scarce [97-100]. Turner et al. 
[100] concluded that no treatment for NSSI, neither for adults nor adolescents, qualifies as 
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empirically supported according to well-established criteria [101]. However, there are some 
treatments that hold promise in the treatment of NSSI. 
2.3.1 PHARMACOLOGICAL TREATMENT FOR NSSI 
Among psychopharmacological treatments for NSSI, five drug classes have been studied: 
SSRI, atypical antipsychotics, SNRI, opioids, and opioid antagonists [100]. A recent Cochrane 
review on pharmacological treatments for self-injury in adults conclude that the low quality 
and small number of conducted trials precludes any conclusions regarding the efficacy of any 
pharmacological intervention [102]. Another Cochrane review on treatments for self-injury 
in children and adolescents from the same year and research group could not identify one 
single trial on pharmacological treatments that met the set criteria to be included in the meta-
analysis [98]. Thus, clinical guidelines state that psychopharmacological treatments should 
not be prescribed as a specific intervention to reduce self-injury [11,103]. 
2.3.2 PSYCHOLOGICAL TREATMENT FOR NSSI  
Randomized controlled trials (RCTs) of psychological treatment effectiveness for NSSI are 
few and the results are inconclusive [100]. Concern has been raised that only a small number 
of therapeutic treatments have been developed and evaluated specifically for NSSI. Most 
studies that have been conducted in the field have included individuals that engage in self-
injury both with and without suicide intent [104]. Failing to distinguish lethal intent and the 
usage of vague and inconsistent terms and definitions makes it difficult to understand what 
mechanisms and behaviors that the different treatments address. One of the most recent and 
thorough meta-analysis on psychotherapeutic treatment for self-injury [99] identified 
dialectical behavioral therapy for adolescents (DBT-A [105]) and mentalization-based 
treatment for adolescents (MBT-A [106]) to be potentially effective for NSSI2. However, when 
analyzing NSSI separately from suicide attempts, neither DBT-A nor MBT-A were superior 
to treatment as usual [99]. In another systematic review of interventions for NSSI in both 
adolescent and adult populations, Turner and colleagues [100] concluded that among the 
interventions that may be effective in reducing NSSI frequency are dialectical behavior 
therapy (DBT [72]), emotion regulation group therapy (ERGT [107]), manual-assisted 
cognitive therapy [108], and dynamic deconstructive psychotherapy [109]. DBT is the 
treatment that has been most extensively researched and is often the treatment of choice. 
However, results regarding the efficacy of DBT for NSSI are mixed. At least three RCT:s have 
shown that DBT leads to greater reductions in NSSI frequency when compared to TAU 
[105,110,111], whereas two other RCTs demonstrated that reductions in NSSI frequency 
were not statistically significant when DBT was compared to active control conditions 
[112,113]. Furthermore, the most popular treatments for NSSI (i.e., DBT and MBT) do not 
                                                        
2 Cognitive behavioral therapy (CBT) was also identified as a promising treatment in this meta-analysis; however, 
the study that examined CBT only included suicide attempts as an outcome, not NSSI. 
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only aim at reducing NSSI-frequency, but also other symptoms of BPD, and the treatments 
are comprehensive, time-consuming, and costly (one to two years of treatment including 
both weekly individual therapy sessions and skills training in group). Therefore, less 
intensive, shorter, focused and less expensive psychological interventions have been called for 
by researchers and clinicians [114].  
2.3.3 EMOTION REGULATION GROUP THERAPY (ERGT) 
ERGT [107] is an acceptance-based behavioral therapy that was designed to address the need 
for an effective short-term, focused and easily implemented treatment for adults with NSSI. 
This 14-week long ERGT is administrated adjunctive to treatment as usual and aims at 
reducing NSSI for individuals with NSSI by directly targeting both NSSI and its proposed 
underlying mechanism - difficulties in emotion regulation. A newly conducted RCT on 
ERGT for adult women with BPD and self-injurious behaviors showed significant effects on 
NSSI and other self-destructive behaviors, BPD-symptoms, depression, anxiety, and emotion 
dysregulation [115]. These findings are consistent with previous studies evaluating ERGT 
[107,116].  
2.3.4 MECHANISMS OF CHANGE IN THE TREATMENT OF NSSI  
One of the most important research gaps within the field of psychotherapy research is to 
understand the mechanisms through which therapy leads to change [117,118]. Increased 
knowledge in this field has the potential of making already effective treatments even more 
effective. However, even for the most well-studied treatments, little is still known about the 
therapeutic mechanisms [119]. A first step to understand mechanism of change is through 
mediational analysis; that is, to study if a construct shows significant relationships between an 
intervention and outcome. To date, there are only a handful of studies investigating  
mediators in psychological treatments of NSSI [105,106,120-122]. Two papers have so far 
been published on potential mediators in ERGT, lending some support for the hypothesis 
that improvement in emotion regulation (as measured with the DERS) contributes to 
reduction in NSSI [120,121]. However, emotion regulation has to the best of my knowledge 
never been shown to mediate treatment outcome in adolescents. 
2.4 ONLINE PSYCHOLOGICAL TREATMENT 
Guided internet-based CBT (ICBT) has been shown to be effective for several mental 
disorders, such as depression and anxiety disorders in both adults (for a review, see Anderson 
[123]) and adolescents (for a review, see Vigerland et al. [124]). In guided ICBT, the therapy 
is based on online self-help material, supported and guided by a therapist communicating 
through the online platform [123]. A systematic review provides evidence that ICBT is at least 
as efficacious as traditional CBT for adults across a range of disorders [125]. One of the main 
advantages of ICBT compared to traditional CBT administered face-to-face is that it can 
increase the accessibility to evidence-based interventions [118]. Not only does ICBT carry the 
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potential to eliminate effects of geographical distance between therapist and patient and allow 
for less therapist time per patient. ICBT may also be perceived as convenient as patients do 
not have to schedule therapist appointments during their work or school day and can interact 
with the treatment manual when it suits them. Furthermore, there is research indicating that 
individuals with stigmatizing illnesses are more likely to use the internet than traditional 
health care to seek help [126]. Indeed, a recent study showed that one third of adolescents and 
young adults with a prior history of NSSI, reported that they had used the internet for help-
seeking [127], suggesting that online treatment may be particularly useful in the treatment of 
NSSI. Although, there have been some recent efforts to treat suicidal thoughts and behaviors 
through the internet (e.g., [128,129]), online therapy has to the best of my knowledge never 
been studied specifically for NSSI. 
2.5 SUMMARY 
NSSI and NSSI disorder are common, particularly among adolescents, and have been 
associated with a variety of adverse outcomes, including various forms of psychopathology 
and suicide attempts. It has been recommended to study self-injury separately from suicidal 
behaviors to better understand its etiology and maintaining factors, thus informing 
assessment, clinical care and treatment development. Emotion regulation may be important 
in understanding NSSI, and the DERS is a useful measure of the construct. DBT and MBT 
have gained some support for their potential effects on NSSI, however the results are mixed 
and these treatments are not available to all. ERGT has shown promise in reducing adult NSSI 
and related difficulties among adult women. There is preliminary evidence that emotion 
regulation, as measured with the DERS, is a potential mechanism of change in ERGT. Several 
studies indicate that online interventions could increase the availability of effective 
treatments. However, online interventions have never been evaluated specifically for NSSI.
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3 AIMS OF THE THESIS 
The aim of the present thesis was to study clinical and psychosocial correlates and outcomes 
associated with NSSI, to develop a brief measure of emotion regulation, and to develop and 
evaluate novel treatments that can be easily and widely implemented for individuals who 
engage in NSSI.  
The specific objectives and hypotheses for each study in this thesis were:  
Study I:  Objective: To compare the clinical and psychosocial correlates and subsequent 
adverse outcomes of youths with self-harm (SH), SH and suicidal ideation and 
behaviors (SH+SIB), and adolescents without any indication of SH or SIB. 
Hypothesis: We expected that the presence of SH and SH+SIB would be 
associated with a higher problem load and subsequent adverse outcomes 
compared with clinical controls. Further, we expected adolescents who 
presented with SH+SIB to be more burdened and have poorer long-term 
outcome than patients with only SH. 
Study II:  Objective: To develop a brief version of the DERS (the DERS-16) and evaluate 
its psychometric properties.  
Hypothesis: We expected that the DERS-16 would demonstrate high internal 
consistency and test-retest reliability. We also expected that the strength of the 
associations of the 36-item and 16-item versions of the DERS with measures of 
relevant constructs would be comparable.  
Study III:  Objective: To investigate the feasibility and utility of ERGT when administrated 
in Swedish psychiatric health care. 
Hypothesis: We hypothesized to find significant improvements from pre-
treatment to post-treatment in NSSI and other self-destructive behaviors, 
difficulties in emotion regulation, psychiatric symptoms, and adaptive 
functioning, as well as stability of these improvements during the 6-month 
follow-up period. 
Study IV:  Objective: To examine the feasibility, acceptance, utility of, and potential 
mechanism of change in, emotion regulation individual therapy (ERITA) when 
delivered face-to-face  
Hypothesis: We expected that the credibility and acceptability of ERITA would 
be high and that we would find significant improvements from pre- to post-
treatment in NSSI, other self-destructive behaviors, emotion regulation 
difficulties, and BPD symptoms, as well as stability of these improvements 
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during a 6-month follow up period. Finally, we also expected that change in 
emotion regulation difficulties would mediate improvements in NSSI during 
treatment.   
Study V:  Objective: To investigate the feasibility, acceptability, and utility of, and 
potential mechanism of change in, ERITA administered online.  
Hypothesis: We expected high levels of treatment module completion and low 
treatment attrition and that the credibility and satisfaction of this treatment 
would be high. Further, we expected to find significant improvements from pre- 
to post-treatment in NSSI, emotion regulation difficulties, acceptance, global 
functioning, BPD symptoms, as well as parents’ ability to respond effectively to 
their children’s negative emotions. We also anticipated that these 
improvements would be maintained or further improved upon during 3- and 6-
month follow up periods. Finally, we hypothesized that change in emotion 
dysregulation would mediate improvements in NSSI and self-destructive 
behaviors during treatment. 
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4 EMPIRICAL STUDIES 
The studies included in this thesis cover a broad field of research including epidemiology, 
psychometrics, and intervention studies within the field of NSSI and emotion regulation. In 
this thesis, I have chosen to present the most recent study first, as it provides a good 
foundation for the following studies. Thus; first, I describe how we explored clinical and 
psychosocial correlates and subsequent adverse outcomes in adolescents presenting at child 
and adolescent mental health services (CAMHS) with SH and SH+SIB compared to clinical 
controls. Second, I depict the process of developing and evaluating a brief self-report measure 
that assesses difficulties in emotion regulation, a construct that may play an important role in 
the development, maintenance, and treatment of NSSI. Third, I outline how we evaluated 
ERGT in a multi-site feasibility trial for adult women with NSSI. Fourth, I describe the 
adaption of the ERGT-treatment for adolescents and the evaluation in an uncontrolled face-
to-face pilot study. Finally, in an attempt to increase accessibility to psychological treatment 
for NSSI among adolescents, I outline how the adolescent treatment was adopted to an online 
format and studied in an uncontrolled pilot study.  
The methods for these studies are thoroughly described in the respective papers. In this 
section, I will describe the methods and results for each study briefly and take the opportunity 
to complement some of these descriptions with additional information and results not 
mentioned in the papers.  
4.1 STUDY I: CLINICAL AND PSYCHOSOCIAL CORRELATES AND 
SUBSEQUENT ADVERSE OUTCOMES OF SH AND SH+SIB 
There is a need for large studies comparing correlates and outcomes between individuals with 
SH, SH+SIB, and clinical controls without SH or SIB. If it could be shown that these groups 
differ in terms of clinical correlates and adverse outcomes this would bring the field forward 
in terms of diagnostic and phenomenological clarity and should inform both risk assessment 
and treatment.  
4.1.1 METHODS 
We conducted a case-control study and a longitudinal cohort study using data from a 
regional clinical care register in Stockholm County Council that was linked to several Swedish 
national registers. The case-control study included all patients (5-17 years) within CAMHS 
between 2011 to 2015 (N = 25,161). Cases with SH and SH+SIB were compared with controls 
(patients without SH and SIB) regarding clinical care consumption (i.e., number of CAMHS 
visits, admissions to and number of nights in psychiatric inpatient care, and psychotropic 
medication), global functioning, mental disorders, and psychosocial problems. The 
longitudinal study included adult former CAMHS patients (N = 5,370) who were followed for 
a median time of 2.8 years after termination of CAMHS contact regarding the following 
outcomes: (1) any record of alcohol or substance use disorder; (2) recurrent care due to self-
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injury; (3) psychiatric inpatient care; (4) dispensed psychotropic medication; (5) social 
welfare; (6) conviction/suspicion of a violent crime; and (7) conviction/suspicion of a non-
violent crime.  
4.1.2 RESULTS 
In the case-control study, the SH group had more visits to CAMHS (β = 7.3, 95% CI [5.3–
9.6]), lower global functioning (β = -1.9; 95% CI [-3.1–-0.8]), and higher odds of having 
depressive (OR = 2.3; 95% CI [1.7–3.1]), anxiety (OR = 1.8; 95% CI [1.4–2.4]), and eating 
disorders (OR = 1.8; 95% CI [1.1–3.2]) compared to controls. In most comparisons, the 
SH+SIB group had more problems than the SH group. In the longitudinal study, the same 
pattern emerged for most outcomes; for example, the adjusted hazard ratio (HR) for 
recurrent care due to self–harm was 23.1 (95% CI [17.0–31.4]) in the SH+SIB group 
compared to HR = 3.9 (95% CI [2.3–6.7]) in the SH group. The corresponding HRs for 
inpatient care were 11.3 (95% CI [8.9–14.4]) vs. 1.7 (95% CI [1.0–2.7]), and for social welfare: 
2.6 (95% CI [1.6–4.3]) vs. 1.5 (95% CI [0.8–2.7]). 
4.1.3 CONCLUSIONS  
Adolescents presenting to CAMHS with SH are more burdened in terms of clinical care, 
global functioning, mental disorders, and psychological problems, than clinical controls. 
Furthermore, this is a patient group with higher risk for several important adverse outcomes 
in emerging adulthood. The SH+SIB group were even more burdened and had even greater 
risks than the SH group in most comparisons. The results indicate a worse prognosis among 
CAMHS patients who present with SH and substantially worse among those with SH+SIB, 
which suggest that both SH and SIB need to inform risk-assessment and treatment.  
4.2 STUDY II: DEVELOPMENT OF A BRIEF VERSION OF THE DERS (THE 
DERS-16) AND AN EVALUATION OF ITS PSYCHOMETRIC PROPERTIES  
Findings from Study I highlight the importance of developing and evaluating early 
interventions for individuals with NSSI. In the process of evaluating interventions it is 
essential to also study potential mechanisms of change. As mentioned in the Introduction, 
there is preliminary evidence that emotion regulation (as measured with the DERS) mediates 
reductions of NSSI following treatment [120,121]. However, in the study of potential 
mechanisms of change it is important that both the mediator and the outcomes are assessed 
frequently with tight intervals during the treatment [130]. If a scale is to be administered 
often (e.g., weekly) it must be brief. A brief measure can also be used in clinics with limited 
time resources and large-scale epidemiological studies. Thus, a shortened version of the DERS 
would likely be an important contribution to clinicians and researchers. 
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4.2.1 METHODS 
We developed a brief version of the DERS (the DERS-16) in collaboration with Dr Gratz (the 
author of the original DERS). The short-form was developed on the basis of both item-total 
correlations (on data obtained from the original study of the full-length version of the DERS 
[96]) and considerations regarding content validity. The psychometric properties of the 
DERS-16 were studied parallel to the ERGT study (Study III, see below) in a Swedish clinical 
sample (N = 96) and two US community samples (Ns = 102 and 482). The DERS-16 was 
administered twice for 31 participants to evaluate its test-retest reliability. The convergent and 
discriminant validity of the DERS-16 was examined comparing the strength of the association 
of the DERS-16 and the original DERS with measures of emotion regulation and related 
constructs, psychopathology, and clinically relevant behaviors theorized to stem from 
difficulties in emotion regulation.  
4.2.2 RESULTS  
Results demonstrated that the DERS-16 showed excellent internal consistency (Cronbachs’ 
α = .92–.94), good test-retest reliability (ρI = 0.85; p < 0.001), and good convergent and 
discriminant validity, and saves administration time compared to the 36-item version (p < 
.001). Further, the DERS-16 demonstrated small differences in its convergent and 
discriminant validity with relevant measures when compared to the original DERS.  
4.2.2.1 Additional Results 
The factor structure was not explored in the published paper on Study II because we 
suspected the study to lack adequate power for a confirmatory factor analysis (CFA) of the 
five sub-scales included in the DERS-16 (i.e., nonacceptance of negative emotions, inability to 
engage in goal-directed behaviors when distressed, difficulties controlling impulsive 
behaviors when distressed, limited access to emotion regulation strategies perceived as 
effective, and lack of emotion clarity). However, a CFA was conducted after this paper was 
published on the Swedish clinical sample (N = 96) using the lavaan R package for structural 
equation modeling [131]. In this CFA, a maximum-likelihood estimation with robust 
standard errors, suitable for data that are not normally distributed, was employed. The CFA 
demonstrated that the chi-square test of goodness-of-fit was significant, χ2(94) = 136.98 
which indicates poor model fit. However, RMSEA = 0.069 (90% CI, 0.045, 0.090), SRMR = 
0.085, and CFI = 0.954 suggests acceptable model fit [132]. 
4.2.3 CONCLUSIONS 
The DERS-16 offers a valid and brief method for the assessment of overall emotion regulation 
difficulties. Post-hoc analyses provide preliminary evidence that the DERS-16 may also be 
used to assess the construct’s different facets.  
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4.3 STUDY III: FEASIBILITY AND UTILITY OF A NOVEL TREATMENT 
FOCUSING ON EMOTION REGULATION –ERGT– WHEN 
ADMINISTRATED IN SWEDISH PSYCHIATRIC HEALTH CARE 
Difficulties in emotion regulation was significantly correlated with NSSI in two out of three 
samples in Study II. One treatment that was designed to decrease NSSI in adults by targeting 
difficulties in emotion regulation is ERGT. However, ERGT had never been evaluated in 
traditional clinical settings and the extent to which ERGT could be disseminated to 
community clinicians was not clear. 
4.3.1 METHODS  
4.3.1.1 Adapting the ERGT-manual to a Swedish context 
We translated the ERGT manual as well as the adherence and competence forms to Swedish 
in close collaboration with Drs Gratz and Tull (the authors of the ERGT manual). Examples 
and metaphors from the manual were culturally adapted, to better suite a Swedish context.  
4.3.1.2 Therapist selection and training 
An open invitation was addressed to potential participating therapists and clinics was 
distributed using different national networks. The therapists were required to have a 
regulated profession (e.g., a licensed nurse or psychologist) and have basic training in CBT 
(preferably with additional training in acceptance and commitment therapy and/or DBT). 
When we selected the participating clinics, we also considered the clinics geographical 
location (to assure geographical representation). We selected 15 clinics (out of 32 which had 
responded to the invitation), with two therapists per clinic. Thirty clinicians were thus 
provided with the ERGT-manual and relevant articles on NSSI and the theory underlying the 
treatment. The therapists were instructed to study this material before participating in a 
three-day ERGT workshop delivered by the originators of the treatment Drs. Gratz and Tull. 
During this workshop, the therapist not only learned how to deliver ERGT but we also 
provided detailed instruction on the study procedures. Before the study started, we also 
visited all clinics to ensure that the therapists understood the procedures and to identify 
potential local barriers to follow study procedures. The participating clinics were reimbursed 
for the administrative costs of the implementation. 
4.3.1.3 Design 
Ninety-five women (aged 18-49; m = 25.1; sd = 7) with threshold and subthreshold BPD and 
repeated NSSI were included in a multi-site trial, using an uncontrolled trial design with 
online assessments at pretreatment, post-treatment, and 6-month follow-up. The primary 
outcome was NSSI frequency. Secondary outcomes included NSSI versatility, difficulties in 
emotion regulation, other self-destructive behaviors, depression, anxiety, stress symptoms, 
and interpersonal and vocational difficulties. The study was conducted at 14 adult outpatient 
psychiatric clinics across Sweden. A total of 17 ERGT group treatments were conducted. All 
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sessions were filmed and reviewed to ensure therapists’ treatment adherence and facilitate 
treatment supervision.	 	
4.3.2 RESULTS 
Ninety-three percent of the participants completed the post-treatment assessment and 88% 
completed the follow-up assessment.	At post-treatment, analyses revealed a significant 
increase in past 4-month NSSI abstinence (17.9%; p < .001), moderate effect size on NSSI 
frequency (52% reduction, 95% CI [33, 66]; Cohen’s d = 0.52, 95% CI [0.30, 0,75]),	as well as 
significant improvements in NSSI versatility (d = 0.41, 95% CI [0.19, 0.63]), difficulties in 
emotion regulation (d = 0.91, 95% CI [0.63, 1.20]), other self-destructive behaviors (29% 
reduction, 95% CI [14, 41]; d = 0.43, 95% CI [0.20, 0,65]), and general psychiatric 
symptomatology (ds = 0.30-0.50). These results were either maintained or further improved 
at 6-month follow-up; for example, NSSI abstinence increased significantly (25.3%; p = 0.01) 
between post-treatment and follow-up. 
4.3.3 CONCLUSIONS 
ERGT seem to be a feasible, useful, and transportable treatment for NSSI and other self-
destructive behaviors, difficulties in emotion regulation and psychiatric symptoms when 
delivered by clinicians in the community for adult women with subthreshold or threshold 
BPD.  
4.4 STUDY IV: FEASIBILITY, ACCEPTANCE, AND UTILITY OF EMOTION 
REGULATION INDIVIDUAL THERAPY FOR ADOLESCENTS (ERITA) 
As demonstrated in Study III, ERGT is a useful treatment for NSSI among adults. However, 
there is still a need for viable treatment options for adolescent with self-injurious behaviors. 
As previously described, the onset of NSSI is in early adolescence, and early interventions 
may potentially prevent later adverse outcomes. The principles of teaching emotion 
regulation skills for individuals with self-injury has proven to be effective in our and previous 
ERGT studies and we wanted to investigate if this treatment could be effective for adolescents. 
We began with conducting a pilot trial to investigate the potential feasibility and utility of 
ERITA, an individual treatment based on the ERGT protocol.   
4.4.1 METHODS 
4.4.1.1 Adapting the ERGT treatment to adolescents 
Rationale for the individual treatment format. The adaptation of the treatment manual was 
conducted in close collaboration with Drs. Gratz and Tull. After careful consideration, it was 
decided that the adolescent version of ERGT would be delivered as an individual treatment as 
opposed to a group treatment. The main rationale for this was to improve safety for the 
participants. There is research indicating that frequency of self-injury may sometimes be 
influenced by social contagion (for a review, see Jarvi et al. [41]). Further, although 
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psychological interventions for adolescents that include group elements may be effective (e.g., 
MBT-A [106] and DBT-A [105]), some research indicates that group therapy for self-
injurious behavior does not always lead to reductions in the behavior [133] and can even lead 
to increased self-injury frequency [134]. Although MBT-A and DBT-A show preliminary 
efficacy in reducing self-injurious behaviors, these treatments are combinations of group and 
individual therapy, allowing the risk for social contagion to be specifically addressed in the 
individual therapy. As this is not the case in ERGT, the ERGT-protocol was adapted from a 
group format to an individual format. Because ERGT is a structured treatment focusing on 
providing patients with skills (i.e., a skills group) rather than being an unstructured group 
where the group members talk about their difficulties and get support from one another (i.e., 
ERGT is not a process group), this was a fairly straightforward process, accomplished by 
adapting the group exercises to individual exercises. ERITA delivered in an individual setting 
offers a number of potential advantages over a group therapy approach. These may include: 
(a) no risk for the adolescents to reinforce NSSI amongst the other group members, (b) the 
treatment interventions can be tailored in a greater degree for the specific individual and 
his/her context, and (c) the treatment can be delivered in the respective participant’s own 
pace.  
Condensing the treatment. We also wanted the treatment to be shorter than ERGT in order 
to fit in one school semester. We therefore deleted one treatment session and combined four 
other sessions into two sessions (i.e., the session on primary vs. secondary emotions was 
combined with the session on clear vs. cloudy emotions, and the session on valued direction 
was combined with the session on commitment to valued actions). Further we added one 
final session on relapse prevention aiming to help the adolescent to identify which skills that 
had been most helpful, identifying risk situations, and strategies for preventing relapse. These 
changes resulted in a total of twelve sessions.  
Impulsivity. As there is evidence indicating that impulsivity peaks during adolescence [135] 
we moved the impulse control session to a place earlier on in the treatment (session 2) to be 
able to provide skills for this in the beginning of the treatment. We also put more emphasize 
on other impulsive destructive behaviors (e.g., drinking, purging, and impulsive self-
destructive sex) throughout the whole course of the treatment.  
Youth-friendly design. The treatment was made more youth friendly by making the 
homework sheets simpler, including applying a youth-friendly design and format 
(incorporating colorful illustrations) and examples appropriate for adolescents. 
Parent program. We included a parent program because parents are a significant part of the 
adolescents’ daily life, and research indicates that family support is important in the treatment 
of adolescents with NSSI [136]. The parent program was developed as an online program 
with therapist support. This program consisted of seven online modules including 
information about NSSI and other risky behaviors, emotional awareness, effective 
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communication skills (e.g., validation [72]), and strategies to increase healthy activities (both 
together with the adolescent and for him- or herself), conflict management, and problem 
solving. 
Safety precaution. In accordance with Swedish law, the therapists were legally obliged to 
share information about the adolescent´s health condition on the caregivers’ request 
(although, from the age of 15 the adolescent gain gradually increasing right to integrity by 
law). However, given that we as therapists needed to be able to fully rely on the adolescent’s 
reports about their own well-being and the adolescent may feel a need to censor what they tell 
us if they do not want their parents to have access to certain parts of their life, therapists have 
to balance the need for parent involvement and what is best from a psychotherapeutic 
standpoint. This was achieved by making a pre-treatment agreement with the parent and the 
adolescent, including mutual understanding on how and under what circumstances 
information about the adolescent was to be shared with the parent. This usually meant that 
we made sure that the parents were fully aware of the methods, frequency and severity of their 
child’s self-injurious behaviors and potential suicidal ideation at baseline. The agreement 
clearly stated that the parent would be informed only if the adolescent’s mental health 
deteriorated and/or if new information had emerged. However, it was up to the adolescent to 
choose how their parent would receive the information, for example the adolescent could 
choose to (1) talk to the parent(s) him-/herself or (2) ask the therapist to do it together with 
him/her or (3) that the therapist informed the parents without the adolescent being present. 
Our aim was to provide the youth with maximum sense of control over how the 
communication took place, without having to compromise with regard to what information 
was shared.  
Because NSSI is one of the strongest predictors for future suicide attempt [67-69], we needed 
to have a safety system around the patient and family. First, the participants were instructed 
to complete online weekly assessments of NSSI and suicidal ideation in order to detect 
sudden deterioration. Further, a crisis plan, involving concrete steps for the adolescents to 
take if they found themselves in a risk situation (e.g., increased suicidal ideation), was 
established before treatment start. This crisis plan was individualized for each adolescent who 
had agreed to each step in the crisis plan. The main function of the plan was to (1) make sure 
that the family had all the contact information required if the adolescent deteriorated and was 
in need of professional help (e.g., phone numbers) and (2) make a commitment together with 
the adolescent (and parent[s]) as to what they should do in case of emergency.  
4.4.1.2 Study design 
Seventeen girls (aged 13–17; m = 15.3; sd = 1.4) with NSSI disorder and their parents were 
included in an uncontrolled open pilot study. Self-report and clinician-rated instruments of 
the primary outcome NSSI and the secondary outcomes of other self-destructive behaviors, 
difficulties in emotion regulation, BPD features, and global functioning were administered at 
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pre-treatment, post-treatment, and 6- month follow-up. NSSI and difficulties in emotion 
regulation were also assessed weekly during treatment. All sessions were filmed to facilitate 
treatment supervision and ensure therapists’ treatment adherence. 
4.4.2 RESULTS 
The rate of treatment completion (88%) and ratings of treatment credibility and expectancy 
were satisfactory, and both treatment attendance and ratings of therapeutic alliance were 
strong (see Table 2 for a summary of the results). Analyses revealed significant improvements 
in past-month NSSI abstinence (p = 0.031) and large effect sizes in past-month NSSI 
frequency (42% reduction, 95% CI [8, 64]; Cohen’s d = 1.14, 95% CI [0.60, 1.95]), emotion 
regulation difficulties (d = 0.81, 95% CI [0.23, 1.50]), self-destructive behaviors (44% 
reduction, 95% CI: 5, 67, d = 0.82, 95% CI [0.23, 1.81]), and global functioning (d = 1.08, 95% 
CI [0.51, 1.62]), as well as a medium effect size in past-month NSSI versatility (d = 0.50, 95% 
CI [0.07, 0.78]), from pre- to post-treatment. Moreover, all of these results were either 
maintained or further improved upon at 6-month follow-up (see Table 2). Finally, the 
indirect effect of time in treatment on NSSI improvement through change in emotion 
regulation was significant (ab = −0.02, SE = 0.01, p = .046).  
4.4.3 CONCLUSIONS 
Results provide preliminary support of the acceptability, feasibility, and utility of ERITA for 
adolescents with NSSI disorder. Further, change in difficulties in emotion regulation 
mediated improvements in NSSI over the course of treatment. 
4.5 STUDY V: FEASIBILITY, ACCEPTANCE, AND UTILITY OF ONLINE ERITA 
One of the aims of this thesis was to develop a novel, targeted, and effective intervention that 
could be easily and widely implemented at a low cost. As an aforementioned review [122] 
shows, ICBT is effective for several psychiatric symptoms, including depression and anxiety 
disorders in adolescents. Moreover, ICBT carries several advantages compared to traditional 
face-to-face treatments that can increase accessibility to psychological treatment and may be 
particularly useful for individuals with stigmatizing illnesses given its association with shame 
[80] and low levels of disclosure [79]. Thus, following the development and pilot testing of 
ERITA face-to-face, we developed and evaluated an online version of this novel treatment. 
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4.5.1 METHODS  
4.5.1.1 Development of the online ERITA 
Several online psychological treatments for children and adolescents have been developed 
and evaluated [137-141] within the Child Internet Project (Barninternetprojektet; BIP) in 
Sweden since 2011. The BIP-platform was also used for the evaluation of online ERITA. This 
platform is entirely web-based, designed to be used by both adolescents and their parents and 
includes age-appropriate design, animations, and interactive scripts (see Figure 2). We made 
some modifications to the content in both the adolescent and parent treatment in response to 
therapist and participant feedback from the Study IV.  
Figure 2. Screenshots of treatment module overview, interactive scripts, and psychoeducative 
animations and texts in online ERITA 
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Modifications to the adolescent treatment. The online ERITA included a greater emphasis 
on the practice of emotional approach strategies throughout the treatment, compared to face-
to-face ERITA. As mentioned previously, there is a convincing body of research suggesting 
that NSSI is a negatively reinforced behavior (i.e., serves an avoidant function). Avoidance 
strategies are problematic, in part because they may prevent the extinction of conditioned 
emotions [142]. One way to address this could be repeated exposure to the stimuli that elicits 
the emotion while at the same time blocking the avoidance response [143], which has been 
suggested as an intervention for NSSI [71]. Explicit rationale for both imaginal and in-vivo 
exposure exercises was therefore included in the online treatment protocol of ERITA. Hence, 
the participants were instructed to identify and actively approach stimuli that elicit emotions 
that historically have triggered NSSI episodes for the individual (however, as discussed later in 
this thesis, some of these instructions have been removed in the online protocol that currently 
is being evaluated in a new trial). Further modifications in the online ERITA included moving 
information on valued directions and actions to the first module (vs. the end of treatment) to 
provide a rationale for approaching/exposing to emotions early in treatment. Finally, the four 
sessions on emotional acceptance, awareness, and clarity were combined into two modules, 
and the two sessions on emotional unwillingness and willingness were combined into one 
module.  
Modifications to the parent program. In response to therapist and participant reports, we 
wanted to place greater emphasis on emotional awareness and validation in the parent 
program. This was done by replacing the conflict-management and problem-solving sessions 
with one module on the function and awareness of emotions and two modules on validation 
and invalidation. In addition to this, the parents got access to the adolescents’ treatment, week 
by week (i.e., pdfs of psychoeducation and exercises, not answers provided by the adolescent) 
in order for the parents to be informed about the content of the treatment. 
Therapist contact. During the course of the treatment (i.e., during 12 weeks) therapists 
(licensed psychologists) had regular online contact via the message functions in the BIP-
platform with the participants in order to reinforce treatment engagement, problem-solve 
and answer questions when necessary, as well as assisting them in planning and reviewing 
homework assignments (see Figure 3). The assigned therapist was the same clinician that 
conducted the intake interview.  
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 Figure 3. Screenshots of the message functions in online ERITA  
The app. We developed a mobile app for this study as a complement to the online treatment. 
In the face-to-face ERITA, participants reported self-destructive behaviors and impulses to 
engage in these behaviors by completing daily pen and paper worksheets. However, inspired 
by ambulatory assessment [144], the app provided the participants with the opportunity to 
register self-destructive behaviors, impulses to act destructively, and on potential protective 
factors, on a daily basis. Furthermore, the mobile app (see Figure 4) included several built-in 
programs providing assistance in the skills acquired in the online treatment (e.g., impulse 
control strategies, emotional awareness and clarity, and distraction and approach strategies), 
and reminders of homework assignments. Further, the crisis plan could easily be accessed 
through the app. 
 
Figure 4. Screenshot of mobile app from online ERITA 
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Participant safety. As in Study IV, participant safety was ensured by pre-treatment 
agreements and weekly assessment of NSSI. In addition to this, the mobile app facilitated 
daily reports of NSSI as well as access to the individualized crisis plan, which may have 
provided additional safety. 
4.5.1.2 Study design 
Twenty-five adolescents (19 girls, 1 boy, 5 other [i.e., non-binary]) aged 13-17 (m = 15.7, sd = 
1.3) with NSSI disorder and their parents were included in an uncontrolled open trial. The 
primary outcome measure was past-month NSSI and secondary outcomes included, NSSI 
versatility, self-destructive behaviors, difficulties in emotion regulation, and global 
functioning. These measures were assessed at pre-treatment, post-treatment, 3- and 6- month 
follow-up. Measures of NSSI, self-destructive behaviors and difficulties in emotion regulation 
were also assessed weekly during treatment.  
4.5.2 RESULTS 
Ratings of treatment credibility, expectancy, and satisfaction were acceptable, and the 
therapeutic alliance and treatment completion rate (96%) were high. No serious adverse 
events were reported. Adolescent participation in the treatment was associated with a 
statistically significant increase in past-month NSSI abstinence (p = .007), large 
improvements in past-month NSSI frequency (55% reduction, 95% CI [29, 72]; Cohen’s d = 
0.88, 95% CI [0.73, 1.06]) and global functioning (d = 1.01, 95% CI [0.77, 1.32]), and medium 
improvements in difficulties in emotion regulation (d = 0.75, 95% CI [0.59, 0.90]) and NSSI 
versatility (d = 0.63, 95% CI [0.54, 0.77]) from pre- to post-treatment. These improvements 
were further strengthened at 3-month follow-up and maintained at 6-month follow-up (see 
Table 2). The online therapist-guided parent program was associated with small to large (ds = 
0.47-1.22) improvements in adaptive parent behaviors, and these results were maintained or 
further improved upon at 6-month follow-up. Further, the indirect relation of time in 
treatment to NSSI reduction through change in emotion regulation difficulties was significant 
(ab = -0.019; 95% CI [-0.045, -0.003]). Likewise, the indirect relation of time in treatment to 
reductions in self-destructive behaviors through change in emotion regulation difficulties was 
also significant (ab = 0.011; 95% CI: 0.025, 0.001).  
4.5.3 CONCLUSIONS 
These results suggest that online ERITA is potentially an acceptable, feasible, and promising 
low-intensity treatment for adolescents with NSSI disorder. Further, in line with the 
theoretical model underlying ERITA, change in difficulties in emotion regulation mediated 
changes in both NSSI frequency and self-destructive behaviors over the course of treatment.  
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4.6 SUMMARY OF THE RESULTS FOR THE FACE-TO-FACE AND ONLINE 
ERITA TRIALS 
A summary of the results from Study IV and Study V are presented below to facilitate 
comparison between the results of the two different treatment formats. 
4.6.1 FEASIBILITY  
In face-to-face ERITA two (12%) participants dropped out of treatment after session 2, 
compared to one participant (4%) who dropped out after the second module in the online 
ERITA. The average number of sessions attended in face-to-face ERITA was 10.29 (sd = 3.37; 
median = 12) out of 12 sessions (86%) compared to the average completed treatment modules 
in online ERITA that was 9.7 (sd = 2.1; median = 11) out of 11 modules (88%). In face-to-face 
ERITA, all enrolled participants completed post-treatment assessments and 15 (88%) 
completed 6-month follow-up assessments. This could be compared to 24 (96%) and 21 
(84%) participants in the online ERITA trial. Moreover, one face-to-face ERITA session was 
60-minutes long (excluding preparations), while the mean therapist time per module for the 
adolescents in online ERITA was 22 minutes. 
4.6.2 ACCEPTABILITY 
In the face-to-face trial, mean ratings of treatment credibility (m = 6.14, sd = 2.07) and 
expectancy (m = 56.43%, sd = 22.74) completed after the first session were satisfactory and 
comparable with mean ratings of treatment credibility (m = 6.5, sd = 1.1) and expectancy (M 
= 55.6%, sd = 21.4) in the online ERITA.  
Two different versions of the Working Alliance Inventory [145] were used in the two trials. 
These versions included different items and different number of items which complicates 
direct comparison. However, the mean score for perceived alliance divided by the number of 
items was 5.4 (sd = 1.7) in the face-to-face trial and 5.0 (sd = 1.3) in the online trial, which 
indicates high and comparable therapeutic alliance. 
 
 
 
 
 
 
 36 
4.6.3 UTILITY 
Table 2. A summary of adolescent treatment outcome variables in Study IV and Study V 
at pre-treatment, post-treatment, and 6-month follow-up 
Measure Pre-treatment Post-treatment 6-month  Pre to post Pre to 6-moth   
Count outcome 
  Study  
Median 
(Q1;Q3) 
Median 
(Q1;Q3) 
Median 
(Q1;Q3) 
% change 
 [95% CI] 
% change  
[95% CI] 
DSHI-9-frequency      
  Study IV F-to-Fa 8 (4;13) 2.5 (0;4.3) 0 (0;3) 42 [8–64] 79 [60–89] 
  Study V Onlineb 9 (3;15) 2 (0;8) 1 (0;6) 55 [29–72] 69 [45–83] 
 Proportion Proportion Proportion p-value p-value 
DSHI-9-abstinence      
  Study IV F-to-F 0% 29% 53% .031 <.001 
  Study V Online 0% 28% 40% .007 <.001 
Continuous outcome 
  Study 
Mean (sd) Mean (sd) Mean (sd) Cohen’s d  
[95% CI] 
Cohen’s d  
[95% CI] 
DSHI-9-versatility      
  Study IV F-to-F 2.1 (1.5) 1.4 (1.2) 0.8 (1.0) 0.50 [0.07,0.78] 0.89 [0.47,1.23] 
  Study V Online 2.2 (1.2) 1.4 (1.3) 0.9 (1.0) 0.63 [0.54,0.77] 1.11 [0.96,1.35] 
DERS      
  Study IV F-to-F 122.7 (17.2) 109.7 (25.2) 100.6 (17.9) 0.81 [0.23,1.50] 1.40 [0.87,2.03] 
  Study V Online 125.6 (20.1) 110.6 (27.2) 99.7 (26.8) 0.75 [0.59,0.90] 1.20 [0.95,1.44] 
BPFSC      
  Study IV F-to-F 70.4 (10.7) 66.9 (12.6) 63.4 (11.3) 0.33 [-0.03,1.11] 0.69 [0.18,1.19] 
  Study V Online 67.1 (12.9) 67.3 (13.9) 64.4 (12.2) 0.02 [0.02,0.03] 0.23 [0.19,0.27] 
CGAS      
  Study IV F-to-F 51.2 (4.9) 56.6 (8.0) 61.1 (11.2) 1.08 [0.51,1.62] 1.94 [1.03 3.12] 
  Study V Online 52.4 (7.1) 60.0 (9.8) 63.2 (10.6) 1.01 [0.77,1.32] 1.44 [1.09,1.88] 
Note. a ERITA administered face-to-face, b ERITA administered online. Test statistics are based on generalized 
estimation equation models using either a negative binomial or normal distribution for count and continuous 
data, respectively. Confidence intervals for Cohen’s d are based on 5000 bootstrap replications. Abbreviations: 
BPFSC = Borderline Personality Feature Scale for Children, CGAS = Children's Global Assessment Scale, 
DERS = Difficulties in Emotion Regulation Scale, DSHI-9-frequency = Deliberate Self-Harm Inventory – 
frequency past month, DSHI-9-abstinence = Deliberate Self-Harm Inventory – abstinence past month, DSHI-9-
versatility = Deliberate Self-Harm Inventory – versatility past month.  
4.7 ETHICAL CONSIDERATIONS 
In research, one has to weigh the importance and potential benefits of the research against the 
risks and burdens to the study participants. All studies in this thesis have been scrutinized and 
approved by appropriate research ethics committees. This thesis includes both intervention 
studies and register-based studies that pose different ethical challenges.  
In Study I, several registers containing sensitive personal information that could harm the 
personal integrity of the study participants were used. Therefore, the identity of the 
participants was protected by the use of a unique identification code, and the researchers did 
not have access to any information that could link the code with a specific individual. 
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Participation in this study did not entail any immediate benefit for the participant. However, 
research using these types of registers can lead to increased knowledge that can inform 
assessment and treatment for others. 
Study II-V include participation in more or less experimental and untested interventions. 
NSSI is associated with a variety of psychiatric issues, confers risk of physical injury, and is a 
risk factor for attempted suicide, presenting researchers and clinicians with a variety of ethical 
challenges that warrant consideration when conducting treatment studies. First, assuring that 
the participants are voluntary agreeing to participate in the research, the study therapists in 
Study II-V, informed the participants (and when appropriate the legal guardians) what they 
could expect if they chose to participate in the research and of their right to discontinue 
treatment. This information was provided in both verbal and written form and contact 
information was given in case of questions or uncertainties. Second, in order to ensure patient 
safety, all therapists received extensive briefing and training in the study protocol and safety 
routines. In addition, regular contact was established between the outpatient clinics, its 
directors and the research group throughout the study, in order to ensure patient safety and 
research integrity. Third, in Study III and IV, all sessions were filmed and reviewed weekly by 
experts in the treatment. This ensured adherence and competence and enabled detailed 
supervision each week. However, filming sessions raises concerns of patient integrity. Thus, 
this procedure was described in both the verbal and written information provided to 
participants. Special care was given to the security involved in uploading, reviewing, and 
storing of the filmed sessions. Fourth, because the participants included in studies III-V 
engaged in high-risk behaviors and may have an increased risk for sudden deterioration in 
mental health and may be in need of acute treatment not offered in these treatment studies, 
all patient contact was delivered within regular psychiatric clinics. This enabled us to use, and 
participants to benefit from, services within the regular care system, such as documentation, 
follow-up inside the health care, and possibility to refer the participants. Fifth, if participants 
were not included in the study or if included participants had not benefited from the 
treatment as intended, the research group facilitated further contact with regular mental 
health care. Sixth, in all intervention studies, screening and assessment of severity of NSSI and 
suicidal ideation was thorough and included weekly assessments of suicidality and frequency 
and severity of NSSI and other potential harmful behaviors. However, this implied an extra 
burden for the participants, and might have been perceived as demanding. To address this 
issue, we put large effort in selecting well-known, short and validated assessment tools in 
order to reduce this burden while at the same time maximizing patient safety and quality of 
data. Seventh, in Study V the treatment was delivered through the Internet. This raised 
unique ethical challenges as face-to-face interactions were limited during the study. However, 
the possibility of daily online contact provided the participant and therapist to communicate 
and detect sudden deterioration in mental health that is not possible in usual health care 
where the patient usually meets with his/her therapist only once or twice a week and does not 
have contact in between sessions. Further, the families had easy access to a crisis plan and if 
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necessary, telephone contact and/or personal visits could be arranged. Thus, in comparison to 
treatment as usual, the intensive surveillance of the patients in Study V could even lead to 
increased patient safety. Finally, all intervention studies included in this thesis were registered 
in the ClinicalTrials.gov trial registry. 
In summary, balancing the need for studying correlates, outcomes, and treatments for 
individuals with self-injurious behavior with the individual need for integrity and safety has 
enabled the research group to include individuals who seldom seek treatment, and who 
would not otherwise have been offered participation in a treatment study. This could 
potentially lead to large benefits for the affected individual, their families, and society at large. 
5 DISCUSSION 
5.1 MAIN FINDINGS 
SH with and without SIB before the age of 18 is associated with clinical and psychosocial 
burden and constitutes a risk factor for several adverse outcomes. Patients with SH+SIB are at 
greater risk than patients with SH only (Study I). ERGT, when implemented in regular health 
care delivered by clinicians in the community appears to be a feasible, transportable, and 
useful treatment for NSSI and related problems among adult women (Study III). The adapted 
version of ERGT for adolescents, ERITA, shows feasibility, acceptability, and utility in the 
treatment of NSSI among adolescents with NSSI disorder (Study IV). Online ERITA is also an 
acceptable, feasible, and promising low-intensity treatment for adolescents with NSSI 
disorder (Study V). The DERS-16 is a brief and valid measure that can be used for repetitive 
assessment of difficulties in emotion regulation (Study II). The DERS-16 was successfully 
used in the ERITA trials, showing that difficulties in emotion regulation mediated week-to-
week improvements in NSSI (Study IV and V), and risk behaviors (Study V).   
5.2 CORRELATES AND ADVERSE OUTCOMES  
Results from Study I confirmed our hypothesis that CAMHS patients with SH had more 
clinical care, lower global functioning, presented with more mental disorders, and 
psychosocial problems than clinical controls. Patients with SH+SIB had even more problems 
in most areas. The findings from the longitudinal study were similar, in which SH was a risk 
factor for several negative outcomes and SH+SIB was associated with even higher risks. The 
results suggest that if an adolescent present to the CAMHS with SH or SH+SIB, clinicians 
need to assess and address the adolescent’s present situation (in terms of global functioning, 
pharmacological treatment, comorbidity, and psychosocial burden). Study I also confirm that 
not only does the present situation need attention, but SH and SH+SIB are associated with 
elevated risks for several adverse outcomes in young adulthood.  
The findings that SH and SH+SIB are associated with elevated risks may not come as a 
surprise to the reader, as problems are often associated with other problems. However, among 
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health care professionals, individuals with self-injurious behavior have been described as 
manipulative and attention-seeking [146], and there are even findings showing examples of 
clinicians perceiving individuals presenting with self-injury as time wasters and unworthy of 
treatment [147]. Indeed, a systematic review on caregiver’s attitudes regarding individuals 
that harm themselves, confirm that both medical and psychiatric staff generally have a more 
negative attitude towards this group of patients compared to other patients [74]. This 
negative attitude is mirrored by experiences of Swedish health care service users with self-
injurious behaviors [148], and the Swedish Agency for Health Technology Assessment and 
Assessment of Social Services concluded that these experiences discourage individuals with 
NSSI from future health care seeking [81]. These findings are consistent with a study showing 
that the majority of adolescents with self-injurious behavior never seek professional help [77]. 
My own personal experiences from project leading and recruiting participants to the clinical 
trials included in this thesis are that many health care professionals are devoted to deliver 
high quality support and professional treatment. However, I have also come across several 
examples of health care professionals that explicitly state that they do not believe that NSSI is 
in itself a reason for specialized psychiatric care, and that self-injurious behavior should be 
ignored and will cease by itself. However, in contrary to this belief, findings from Study I 
stress the importance that individuals with SH and SH+SIB should be a prioritized patient 
group within CAMHS. 
5.3 THE NEED FOR EARLY INTERVENTIONS 
So far, no treatment has consistently been shown to be superior than treatment as usual for 
NSSI [99,100]. Identifying subgroups of individuals with self-injury (e.g., differentiate 
between those who harm themselves with suicidal intent from those without suicidal intent) 
may have relevance for treatment development and treatment planning [98,136,149]. Health 
care interventions are often delivered step-wise, i.e., brief interventions are followed by more 
intense treatments, should improvement fail to appear. For those with higher risk and worse 
prognosis (i.e., those that present at CAMHS with SH or SH+SIB), more specialized 
treatment programs from start should probably be the preferred choice, rather than applying 
a “qualification approach” where access to more advanced or intense treatment is dependent 
on the progression of symptoms and behaviors. For example, based on a literature review of 
intervention studies, Brent et al. [136] recommend initializing treatment during inpatient 
care following an acute self-injurious event. Even though Swedish youth with SH and/or SIB 
commonly are provided specialist level care, more specialized treatments such as DBT or 
MBT rarely are available to those under 18 years of age [150]. Moreover, because these 
treatments are long, intensive, and expensive, it would not be possible to offer these 
treatments to everyone that engages in self-injurious behaviors [151]. A consequence of the 
lack of specific treatment programs for younger adolescents is that substantial time may pass 
between the onset of severe risk behaviors and enrollment in evidence-based interventions. 
Hence, effective early evidence-based treatments for individuals with self-injurious and 
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suicidal behaviors are urgently needed. One suggestion to address this need has been to 
develop adjunctive treatments that may augment the standard therapy provided by clinicians 
in the community [114]. Thus, the treatments that were developed and evaluated in this 
thesis were designed to be short, easily implemented, effective, and possible to deliver 
adjunctive to treatment as usual.  
5.4 FEASIBILITY AND UTILITY OF ERGT IN PSYCHIATRIC HEALTH CARE  
In Study II we implemented ERGT at 14 outpatient clinics delivered by 28 therapists. In line 
with our hypothesis, patient participation was associated with significant improvements from 
pre- to post-treatment in NSSI, other self-destructive behaviors, difficulties in emotion 
regulation, and symptoms of depression and stress. These results were maintained or further 
improved at 6-month follow-up. The results found from this study are similar to those 
obtained in previous ERGT efficacy trials [107,115]. Needless to say, they must be 
interpreted with caution because of the lack of a control group. However, one strength in 
this study was that the therapists had different professions (e.g., nurses, social workers, and 
psychologists) and are thus representative of the therapists who treat this patient population 
in the community. Hence, Study II provides unique data on how the treatment may actually 
perform when provided in routine clinical care under real-world conditions, thus providing 
preliminary support for the generalizability and transportability of ERGT. This type of 
study may play an important role in increasing the availability of an evidence-based 
treatment for NSSI. Indeed, before Study II was conducted, few professionals within 
Swedish psychiatric health care had any previous experience of ERGT. Since this study was 
conducted, we have organized several workshops (held by Drs. Gratz and Tull) and trained 
more than 120 therapists and 12 supervisors in ERGT throughout Sweden. The reasons 
behind this rapid dissemination of ERGT in Sweden is probably due to its promising effects 
[107,115,116] and funding from the National Self-Injury Project, but also due to its relative 
brevity compared to alternatives (e.g., DBT and MBT). Although shorter interventions that 
specifically target NSSI are much-needed, politicians that advocate shorter treatment 
alternatives must always be mindful of the research base of the treatment studies at hand. In 
my opinion, ERGT is a welcomed complement to treatment as usual but independent 
RCTs, including health care economic evaluations, are urgently needed before this novel 
treatment can substitute well-known alternatives. With that said, we have continued to 
collect data for some ERGT-groups after study termination, and it will be interesting to 
follow the ongoing dissemination of ERGT within Swedish health care.  
5.5 FEASIBILITY, ACCEPTANCE, AND UTILITY OF FACE-TO-FACE ERITA 
In line with the objectives and hypotheses, Study IV provides preliminary support for the 
feasibility, acceptability, and utility of ERITA in the treatment of NSSI and related difficulties 
among adolescents with NSSI disorder. Further, consistent with our hypothesis, change in 
difficulties in emotion regulation mediated improvements in NSSI over the course of 
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treatment. These findings add to the literature as the first attempt to study an adapted version 
of ERGT for adolescents, being one of the few treatments specifically developed to address 
NSSI in youth [152-154], and for studying mediation in treatment of adolescent NSSI. 
However, the absence of a control group precludes any conclusions regarding the effects of 
this treatment versus the passage of time or other factors. 
5.6 FEASIBILITY, ACCEPTANCE, AND UTILITY OF ONLINE ERITA 
Study V revealed findings consistent with those obtained in the face-to-face trial, with high 
ratings of treatment credibility and expectancy, therapeutic alliance, and treatment 
satisfaction indicating acceptability. Furthermore, only one participant dropped out of 
treatment, the majority of the participants completed all treatment modules, and no serious 
adverse events were reported, indicating feasibility. Moreover, statistically significant 
decreases in adolescent NSSI and difficulties in emotion regulation and increase in adaptive 
parental behavior suggest utility of online ERITA. These findings were consistent with 
qualitative analyses based on interviews with the adolescent and parent participants in the 
study, conducted as part of a master’s thesis [155], suggesting that the flexibility inherent in 
online format (i.e., when and where the participant could engage in the treatment) and 
support (i.e., online contact with the therapist) were important contributing factors to a 
positive treatment experience. These findings are encouraging given that improving 
treatment compliance for adolescents engaging in NSSI is a critical first step in delivering 
effective treatments [99]. Importantly, however, the mean therapist time per adolescent in 
Study V was approximately one third of the time required in face-to-face ERITA or other 
brief treatments for NSSI (e.g., [152]). This reduction in therapist time was accomplished 
without any apparent loss in the feasibility, acceptance, or utility of the intervention. Thus, 
online ERITA has the potential to offer a specific, brief, and acceptable intervention that 
could easily be implemented in areas without viable treatment options and for adolescents 
who would not engage in treatment otherwise. Needless to say, the findings must be 
interpreted with caution because the absence of a control group limits any conclusions 
regarding causality.  
5.7 MEANINGFUL CHANGE IN THE TREATMENT OF NSSI 
There has been extensive critique against p-values, as it says little about practical importance, 
any particular alpha-threshold is arbitrary, and that the “difference between ‘significant‘ and 
‘not significant‘ is not itself statistically significant” [156, p. 328]. To address this issue, many 
major journals advocate the use of reporting effect sizes. However, even with large Cohens’ ds 
or hazard ratios, it depends on the outcome of interest if the change or risk are of practical 
importance. However, one effect size that without doubt is meaningful is the proportion of 
participants that cease harming themselves in response to treatment. In the adult ERGT-trial, 
the proportion of participants that reported NSSI abstinence (i.e., zero NSSI episodes) the 
past 4 months increased significantly from 4.2% at pre-treatment to 17.9% at post-treatment 
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and to 25.3% at 6-month follow-up. This was lower than in previous ERGT trials [115,116] 
which may, as discussed in the paper, be attributed to differences in the level of therapist 
training provided in the study compared to previous trials or to differences in sample 
composition and/or symptom levels. In the adolescent trials about half of the participants 
reported NSSI abstinence at the 6-month follow-up. Few treatment studies on adolescent 
NSSI report this outcome, however in an evaluation of MBT-A, 44% reported self-injury 
abstinence after 12 months of intervention [106]. This comparison is promising for our 
short, low-intensive therapies for adolescents. 
5.8 BEHAVIOR SUBSTITUTION 
As previously discussed, NSSI decreases for many adolescents during the transition to 
adulthood [63,157]. When studying the behavior over time, it has therefore been 
recommended to follow up a broad range of risky behaviors [63], to answer the question if 
NSSI is substituted by other behaviors, such as alcohol or drug use. Tendencies of “symptom 
shifting” has been found in one study on developmental trajectories of NSSI, suicidal 
behavior and substance misuse [64]. Indeed, in Study I, the risk for alcohol misuse was more 
than doubled in the SH group compared to controls, which may indicate that some 
individuals either acquired an additional risky behavior or substituted self-injury with alcohol 
misuse (though this was never investigated). To control for behavior substitution in our 
intervention studies, we included a measure of risky self-destructive behaviors (the 11-item 
behavior supplement to the Borderline Symptom List [158]). In these studies, the observed 
decrease in NSSI was accompanied by a decrease in in this measure, suggesting that the 
participants had not just replaced NSSI with other risky behaviors. Indeed, as Study V 
implies, increased skills in emotion regulation did not only mediate the decrease in NSSI, but 
also mediated week-to-week decrease in risky behaviors. The preliminary finding that the 
adolescents improve their skills in emotion regulation following ERITA is promising, 
especially considering the increased risks of adverse outcomes (some of which potentially 
could be due to difficulties in emotion regulation) observed in Study I, that these adolescents 
are at risk for in emerging adulthood. 
5.9 MEDIATION 
ERGT and ERITA were developed to reduce NSSI by teaching the participants more adaptive 
ways of responding to their emotions. The two studies on ERITA provide preliminary 
support for emotion regulation as a potential mechanism of change in this treatment of 
adolescent NSSI, as well as the theoretical model underlying the treatment. These findings 
also highlight the clinical utility of targeting emotion regulation in the treatment of NSSI and 
other self-destructive behaviors among adolescents. The mediation analyses were possible to 
conduct given that we assessed both the mediator and outcomes weekly during treatment. 
This is, to my knowledge, the first treatment studies for NSSI that follow recommendations 
for mediation [130] by assessing both the potential mediator and outcome with tight 
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intervals. However, although ERGT/ERITA are considerably more specific than many other 
prevailing treatment models for NSSI, they do include a multitude of emotion regulation 
skills. In order to better understand the role of emotion regulation in the maintenance of 
NSSI, future studies could benefit from dismantling designs isolating particular emotion 
regulation skills (such as emotional awareness or impulse control) by design and test its 
isolated effect on NSSI. An important approach in early treatment development phase is to 
use multiple baseline single-case designs [159]. These types of designs facilitate higher 
experimental control compared to open uncontrolled trials and can still be adopted on small 
sample sizes. These designs coupled with the comparison of short and distinct treatment 
modules may facilitate knowledge on the maintaining factors behind NSSI (see Bentley et al. 
[153] for an interesting example).  
5.10 EXPOSURE 
Explicit rationale for structured imaginal and in-vivo exposure exercises [143] were included 
in the online ERITA protocol. Hence, the participants were instructed to identify and actively 
approach stimuli that elicit emotions that usually triggered NSSI-episodes for them. However, 
during treatment it was evident that it was difficult for the participants to identify defined 
situations for such exposure. This was also verified in the qualitative interviews conducted 
with the participants [155]. In the treatment of other anxiety disorders, such as social anxiety 
disorder or obsessive-compulsive disorder it is often evident which stimuli (e.g., giving a 
speech or leaving the front door) that trigger the conditioned response. However, for 
individuals with NSSI, these situations may vary to a greater degree. For example, research 
has demonstrated a strong link between social rejection and NSSI [160] which often is a 
situation that triggers unwanted emotions that some individual avoids by harming 
themselves. However, the effect of social rejection may vary greatly within one individual in 
different contexts making it difficult to actively identify a situation for exposure. Therefore, 
the explicit rationale for exposure with response prevention has been removed in the revision 
of the online treatment currently being evaluated in a RCT. Instead, a greater emphasis is now 
once again on approaching aversive situations or emotions when they arrive and to flexibly 
try new strategies instead of avoiding (key interventions in ERGT and ERITA). Within this 
framework, behavioral exposure may focus on increasing alternative responses to the stimuli, 
such as approaching or staying in aversive situations or emotions and to flexibly try new 
strategies instead of avoiding [71].  
5.11 HOW IMPORTANT IS THE PERSONAL THERAPIST CONTACT? 
Being a study therapist and supervisor in Study IV and V provided me with clinical 
experience of the same patient group and the same interventions, but with different ways of 
delivering the treatment. I see apparent advantages with the online format. In addition to the 
advantages often mentioned (e.g., accessibility, less therapist time per patient, geographical 
distances, no need to schedule appointments, and less impact of therapist drift [i.e., clinicians’ 
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failure to adhere to treatment protocol]), it may actually be an advantage that the personal 
contact is limited in online treatment. When watching video records of my own and others’ 
sessions it is sometimes apparent that the patient is not mindful during the session, without 
the therapist really noticing this. Sometimes my impression is that the patient is so occupied 
with how he/she/ze is being perceived or with something that happened before the session, 
that it competes with being attentive on learning new skills. Indeed, there is psychotherapy 
research indicating that patients do not remember most of the session content after the 
session [161]. Further, although strong therapeutic alliance may be helpful, the therapist 
contact (e.g., in the case of bad personal matching between therapist and patient) may also 
interfere with therapy, especially for individuals (patients and therapists) with interpersonal 
difficulties. Finally, therapist drift (that is, clinicians’ failure to deliver evidence-based therapy) 
is a common and well-studied barrier for effective treatments [162]. In online therapy, the 
patient can always revisit the session content and may choose to interact with the treatment 
material once he/she/ze is in the right state of mind, and the personal contact is limited to 
online communication.  
It could very well be the case that online contact is less effective than face-to-face contact with 
effective therapists but may at the same time buffer for the potential detrimental effects of 
contact with ineffective therapists. Interestingly, the adolescents rated the therapeutic alliance 
very similar in Study IV and V, indicative that it may be possible to achieve strong therapeutic 
alliance through online contact with adolescents. Worth mentioning though, is that in both 
adolescent trials, the therapists also conducted the initial assessments which may have laid the 
foundation for strong therapeutic alliance. However, in the qualitative analyses of the online 
ERITA, participants reported that they felt supported by the online therapist and that it felt 
safe to share personal thoughts and feelings and attributed that to the online format [155]. In 
summary, repeated face-to-face contact may not be necessary in the treatment of NSSI among 
adolescents due to the structured treatment format, access to the treatment material, and the 
method of communication inherent to online treatment. However, if it would be possible to 
completely omit personal contact is another question (see Andersson [123]).  
5.12 PSYCHOMETRIC PROPERTIES OF THE DERS-16 
In order to be able to assess difficulties in emotion regulation weekly we developed a short 
version of the DERS, the DERS-16. In Study II, the brief version of the DERS demonstrated 
reliability and validity as a global measure of difficulties in emotion regulation. One limitation 
addressed in the paper of this study was that we did not explore the factor structure. The main 
reason was that we suspected the sample size to be insufficient to confirm the five-factor 
structure in a CFA. However, post hoc analyses included in this thesis provide preliminary 
evidence for the proposed factor structure in the DERS-16. Although these findings need to 
be interpreted with caution because of inconsistent model fit indices and low power, they are 
in line with recent studies that have provided independent evidence for the proposed 5-factor 
structure in the DERS-16 [163,164]. Thus, although this short version was developed as a 
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viable option in the assessment of overall emotion dysregulation, the additional analyses 
included in this thesis suggest that the DERS-16 may also be used to study the five different 
facets of the construct. 
5.13 LIMITATIONS 
The studies included in this thesis have some important limitations inherent to their design. 
These include that the registry study was based on administrative data and the treatment 
studies employed uncontrolled designs. Most importantly in Study I, the operationalization of 
cases/controls and exposed/unexposed were based on clinicians’ judgement, and we know 
little about when and how SH and SIB were assessed. In studies III-V, the most important 
limitation was that the uncontrolled open trial design precluded any conclusions regarding 
causal inferences of potential treatment effects. Without control group we do not know if 
other factors may have, at least in part, accounted for the studies’ findings, such as passage of 
time or factors underlying both treatment completion status and symptom improvement 
(e.g., motivation or therapeutic alliance). However, although the uncontrolled designs limit 
the ability to draw conclusions regarding treatment effect they can provide essential 
information on acceptability, feasibility, and potential adverse events associated with the 
treatment and procedure that may inform future RCTs. Recently, one of the largest (N = 832) 
and most expensive treatment studies ever conducted in the field of adolescent self-injury 
failed to provide evidence that a family therapy intervention was beneficial compared to 
treatment as usual [122]. A critique to that trial has been that an untested intervention 
should be explored stepwise [151] in pilot studies before beginning extensive trails. 
Further, the usage of vague and inconsistent terminology for self-inurious behaviors has 
been proposed to be one of the greatest obstacles in the studies of the behavior [149], as 
different definitions may include different phenomena. Although we initially had an 
ambition to be consistent in the nomenclature, we have used several different terms for self-
injurious behavior (i.e., SH, NSSI, and DSH) in the included papers in this thesis. The terms 
NSSI and DSH used in studies II-V has been defined as direct and deliberate destruction of 
body tissue without suicidal intent [165]. However, neither of these terms could be applied 
in Study I. In this study, the raters could choose between “self-injurious behavior” and 
“suicidal ideation and behaviors” as two separate predefined categories. Thus, we had to 
infer that if a clinician only documented SH (i.e., not suicidal ideation and behaviors) this 
would equal NSSI or DSH. However, because we did not know if the clinicians completed 
thorough assessment regarding suicidal intent we refrained from using those terms. During 
the past few years many scientists and clinicians have begun to use more clear and 
consistent definitions of these behaviors [149], which hopefully will improve our 
understanding of clinical registers in the future. 
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5.14 FUTURE DIRECTIONS 
It is evident that self-injury is a serious behavior that needs to be addressed. However, its 
relationship to suicidal behavior needs further exploration. One way to study if there is a 
qualitative difference between nonsuicidal and suicidal behavior may be to study potential 
cross-over between the two behaviors over time, preferably in large registries with little 
missing data. This may inform: (a) if NSSI and suicidal behaviors should be considered as 
separate diagnostic entities, (b) why no single intervention has shown to be superior to 
treatment as usual for NSSI among adolescents when considered separate from suicidal 
behavior [99], and (c) if interventions aiming to reduce NSSI should differ from those aiming 
to reduce suicide attempts. Further research that would improve our understanding of 
maintaining factors of NSSI and how to best intervene may be to expand the research on self-
reported reasons of harming one-self (i.e., to avoid aversive emotional states) by studying the 
biological mechanisms through which this occurs (e.g., endorphin release or distraction). As 
mentioned previously, the evidence base for interventions targeting NSSI is weak [99,100]. 
The novel treatments studied in this thesis all show potential; however, RCTs are needed to 
provide more rigorous data that can speak more broadly of the acceptance, feasibility, and 
efficacy of these treatments. One recent extension of this work is our ongoing RCT 
comparing online ERITA with treatment as usual in a national multi-center study. This study 
does not only carry the potential to speak to the potential efficacy of the treatment, but also 
addresses questions that can be answered by using momentary assessment, mediation 
analyses (including competing mediators), and health economy assessments.   
6 CONCLUSIONS 
Taken together, SH and SH+SIB should inform risk assessment and be prioritized within 
CAMHS. The DERS-16 is a reliable, valid, and brief self-report measure of difficulties in 
emotion regulation with broad clinical and research utility. ERGT is a treatment that can be 
easily implemented within health care and carries the potential to increase access to evidence-
based treatments for NSSI. ERITA may be a promising treatment for NSSI among 
adolescents, both in a traditional face-to-face format as well as in an online format and should 
be evaluated in randomized controlled trials. Also, difficulties in emotion regulation as 
measured with the DERS-16 mediates week-to-week changes in NSSI during adolescent 
treatment, thus providing further preliminary support for the underlying role of emotion 
regulation difficulties in the maintenance of self-destructive behaviors, as well as for emotion 
regulation as a potential mechanism of change in ERGT-based treatments. 
 
  47 
7 ACKNOWLEDGEMENTS 
I am fortunate to have many people to thank, that have supported me through this process 
and made this thesis possible.  
First and foremost, Brjánn Ljótsson my main supervisor, idol, travel companion and dear 
friend. Thank you for giving me the opportunity to do something as rewarding as a doctoral 
education. Thank you for being there for me since day one; always supportive, both 
emotionally and scientifically. Thank you for approaching new subjects with curiosity and not 
always giving me answers but providing me with the skills to find them. I could not imagine a 
better supervisor. Sometimes I wish it was only you and me in a room full of computers. I am 
forever grateful to you.   
Clara Hellner, my co-supervisor. Thank you for taking us under your wings and making these 
projects possible. Thank you for your never-ending eager to learn, I was happy to find out 
that it is contagious. I am proud to work with someone like you. I have no idea how you 
always manage to find the time to keep asking important and critical questions meanwhile 
being the big boss. I look forward to many years of future collaboration. 
Erik Hedman-Lagerlöf, my co-supervisor who knows everything. Thank you for asking the 
questions that made me think one step further. Thank you for always being there. You are not 
only a top-notch supervisor and researcher, you also have stamina like a robot making you 
the number one travel companion. Research is fun with you!  
Jussi Jokinen, my co-supervisor. Thank you for believing in my research project and 
including it in your research application five years ago. Before that the project was only a 
fantasy. Thank you for inviting me to other collaborations that have expanded my horizons. 
Hanna Sahlin, my clinical mentor and doctoral colleague. This thesis would not have been the 
same without you. I will always treasure the adventures that we have had, and our many years 
of joy and deep friendship.  
Ata Ghaderi, my mentor. Thank you for supervising mine and Iman’s master’s thesis, 
threatening us to apply to a PhD-programme, and for being my mentor once I was accepted 
as a doctoral student. 
Kim L. Gratz, colleague, informal supervisor. I never cease to be amazed by your work. There 
more I learn about self-injury, the more I realize how brilliant you are. Thank you for trusting 
us to disseminate your baby in a country whose language you do not speak.  
Matthew T. Tull, colleague, informal supervisor. Thank you for great discussions, proof-
reading this thesis and teaching me how to swing a gun properly – Texas style. 
 48 
Kim and Matthew, thank you for training me and the study therapists in ERGT, providing 
great comments on my manuscripts, feedback on the ERITA treatment protocol, and for 
inviting me to exciting projects. I hope you will let me continue to learn from you many years 
to come.  
Olivia Simonsson, my psychologist under training. Thank you for stepping in the way you 
did. The past six months would have been impossible without you, you saved our asses.  
I want to thank my research group at the Division of Psychology, that is Marianne Bonnert, 
Marie Lalouni, and Josefin Särnholm for wonderful work retreats, discussions, feedback on 
the treatment protocol, collaborations, great food, and wines; and Maria Hedman-Lagerlöf, 
Maria Bragesjö, and Dorian Kern for support and Thursday seminars.  
Eva Serlachius, thank you for generously providing us with guidance from the very beginning, 
for hosting me and our online treatment at the BUP Clinical Research Unit, and for being an 
awesome person.  
Thank you, Sarah Vigerland and Fabian Lenhard for paving the way and sharing dos and 
don’ts. Thank you, Fabian also for providing feedback on the Introduction of the 
summarizing chapter. Thank you, Gunnar and Björn for helping us to build and design the 
online ERITA. Thank you everyone else in the BIP-team: Fredrik, Kristina, Per, Jens, Martina, 
Maral, Tove, Lie, Frida, Fredrik, and Hedvig, for practical help, know-how and hang-outs in 
the lunch room.  
Erik Andersson, thank you for generously involving me in your studies. It was when I 
conducted follow-up interviews in one of your ICBT trials that I realized the impact that 
online interventions can have.  
Thank you Jonas Bjärehed and Lars-Gunnar Lundh for scientific advice, comments on 
papers, and for help with organizing the first ERGT-workshop (it was a nightmare).  
Martin Cederlöf, thank you for granting me access to a new field of research and for always 
being available for discussion. Thank you Paul Lichtenstein and David D’Onofrio for 
feedback on the manuscript.  
Joan Asarnow, Mia Ramklint, Per Lindberg, and Cecilia Mattisson, thank you for critically 
reviewing my thesis. Thank you Nitya Jayaram-Lindström for being my defence chairperson. 
I would like to thank the National Self-Injury Project, the Markus and Amelia Wallenberg 
Foundation, the Swedish Research Council, the Stockholm County Council, the Fredrik och 
Ingrid Thurings stiftelse, the Kempe-Carlgrenska Foundation, the Sven Jerring Foundation, 
and the Bror Gadelius minnesfond for financial support. 
I would like to give thanks to the peer-supporters at SHEDO for generously sharing 
knowledge, doing important work, and for great collaborations. 
  49 
Thank you Niclas Andersson, Sara Eivergård, Anna Jansson, Ida Jansson, Julia Stensils, and 
Linn Bjureberg for help with study administration. 
A big thanks to all of the study therapists for your hard work and enthusiasm, which made 
the intervention studies possible. Thank you for your patience with the millions of routines. It 
has been a pleasure to work with you.  
To all my colleagues at Centre for Psychiatry Research, thank you for providing me with a 
great working environment. In particular I want to thank Eva Klingberg for leading the 
National Self-Injury Project and facilitating a platform for our studies. And for finding me a 
skrivarstuga last summer. Thank you Anders and Kristoffer for interesting scientific 
discussions and gossip. Anna, Karolina, Maria, Andreas, and Elin for research collaborations. 
Kristoffer NT och Robert for focus nights. Anne, Annelie, Christopher, Fredrik, Helena, 
Håkan, Ingvar, Joanna, Lena, Lena, Mattias, Ola, Olof, Sofi, Sofia, Susanna, and Viktor for 
being there. 
To my previous colleagues at Ångestenheten and Neuropsykiatriska enheten, Diana, Simon, 
Johanna, Mia, Volen, Johan, Else, Tatja, and Johan Phanke for being kick-ass clinicians and 
encouraging co-workers. 
Thanks to the brilliant therapists at Borderlineenheten who formed me as a clinician. I 
especially want to thank my DBT role-model Per, and my previous colleagues Lena, Giulia, 
and Marie who encouraged me to do research and teaching me what a DBT-team is all about. 
When I left you the words Christmas party lost meaning.  
To my family for always being there and for not caring too much about my work. Mum, 
thank you for helping me with homework when I was extremely motivated to do everything 
except school. I would not have been able to earn a living on something that I love and that 
gives me meaning without you, I love you. Dad, thank you for giving me my hobbies and 
some jävlar anamma, it has taken me far. Linn, when I grow up I want to be like you. Erik, 
thank you for being my best friend.   
Thank you Komvux for giving me a second chance. Rest in peace. 
Thank you NOCCO, it was a great ride but our relationship must end now.  
Martin, thank you for tennis lessons and proof-reading parts of this thesis. 
Iman, thank you for being my vapenbärare during the psychology programme. I would not 
have been here without you.  
Jon, thank you for being my personal graphical designer and making my thesis a bit sexier. 
Although, I am most grateful for you bringing me on adventures that made me forget about 
research. 
 50 
Henrik and Fabian, thank you for being great friends, keeping me in shape, and keeping me 
company at Max, and for accepting to be my toasties.  
Thank you to all my great friends. You know who you are, but will probably never read this 
far :) 
Fatima, thank you for reminding me of who I want to be and of what is important in life  
– this is life, life immortality. It is you and me habibti <3 
Finally, I want to direct my appreciation to all participants who volunteered to be part of 
these studies. Without you, none of this would have been possible.
  51 
8 REFERENCES 
 
1. International Society for the Study of Self-Injury. Fast facts. 
URL:https://itriples.org/fast-facts/. Accessed: 2018-03-16. Archived at 
http://www.webcitation.org/6xxxwDewB 
2. Klonsky ED, Muehlenkamp JJ. Self-injury: A research review for the 
practitioner. J. Clin. Psychol. 2007;63:1045–56.  
3. Nock MK, Prinstein MJ. A Functional Approach to the Assessment of Self-
Mutilative Behavior. J Consult Psychol 2004;72:885–90.  
4. Whitlock J, Eckenrode J, Silverman D. Self-injurious behaviors in a college 
population. Pediatrics 2006;117:1939–48.  
5. Fox KR, Millner AJ, Franklin JC. Classifying nonsuicidal overdoses: 
Nonsuicidal self-injury, suicide attempts, or neither? Psychiat Res 
2016;244:235–42.  
6. Plener PL, Fegert JM. Non-suicidal self-injury: state of the art perspective of a 
proposed new syndrome for DSM V. Child Adolesc Psychiatry Ment Health 
2012;6:9.  
7. Wilkinson P. Non-suicidal self-injury. Eur Child Adolesc Psychiatry 2013;22 
Suppl 1:S75–9.  
8. Kapur N, Cooper J, O'Connor RC, Hawton K. Non-suicidal self-injury v. 
attempted suicide: new diagnosis or false dichotomy? Br J Psychiatry 
2013;202:326–8.  
9. Hawton K, Hall S, Simkin S, Bale L, Bond A, Codd S, et al. Deliberate self-harm 
in adolescents: a study of characteristics and trends in Oxford, 1990-2000. J 
Child Psychol Psychiatr 2003;44:1191–8.  
10. Klonsky ED. Non-suicidal self-injury in United States adults: prevalence, 
sociodemographics, topography and functions. Psychol Med 2011;41:1981–6.  
11. Plener PL, Brunner R, Fegert JM, Groschwitz RC, In-Albon T, Kaess M, et al. 
Treating nonsuicidal self-injury (NSSI) in adolescents: consensus based 
German guidelines. Child Adolesc Psychiatry Ment Health 2016;10:1–9.  
12. American Psychiatric Association. Diagnostic and statistical manual of mental 
disorders. 5 ed. Washington, DC: Author; 2013.  
13. Glenn CR, Klonsky ED. Nonsuicidal Self-Injury Disorder: An Empirical 
Investigation in Adolescent Psychiatric Patients. J Clin Child Adolesc Psychol 
2013;42:496–507.  
 52 
14. Nock M, Joinerjr T, Lloyd-Richardson E, Gordon K, Prinstein MJ. Non-
suicidal self-injury among adolescents: Diagnostic correlates and relation to 
suicide attempts. Psychiat Res 2006;144:65–72.  
15. Jacobson CM, Muehlenkamp JJ, Miller AL, Turner JB. Psychiatric Impairment 
Among Adolescents Engaging in Different Types of Deliberate Self-Harm. J 
Clin Child Adolesc Psychol 2008;37:363–75.  
16. Glenn CR, Klonsky ED. Social context during non-suicidal self-injury indicates 
suicide risk. Pers Individ Dif 2009;46:25–9.  
17. Plener PL, Libal G, Keller F, Fegert JM, Muehlenkamp JJ. An international 
comparison of adolescent non-suicidal self-injury (NSSI) and suicide attempts: 
Germany and the USA. Psychol Med 2009;39:1549–1510.  
18. Zetterqvist M, Lundh L-G, Dahlström Ö, Svedin CG. Prevalence and Function 
of Non-Suicidal Self-Injury (NSSI) in a Community Sample of Adolescents, 
Using Suggested DSM-5 Criteria for a Potential NSSI Disorder. J Abnorm 
Child Psychol 2013;41:759–73.  
19. Swannell SV, Martin GE, Page A, Hasking P, St John NJ. Prevalence of 
nonsuicidal self-injury in nonclinical samples: systematic review, meta-analysis 
and meta-regression. Suicide Life Threat Behav 2014;44:273–303.  
20. DiClemente RJ, Ponton LE, Hartley D. Prevalence and correlates of cutting 
behavior: Risk for HIV transmission. J Am Acad Child Adolesc Psychiatry 
1991;30:735–9.  
21. Kumar G, Pepe D, Steer RA. Adolescent psychiatric inpatients' self-reported 
reasons for cutting themselves. J. Nerv. Ment. Dis. 2004;192:830–6.  
22. Briere J, Gil E. Self-mutilation in clinical and general population samples: 
prevalence, correlates, and functions. Am J Orthopsychiatry 1998;68:609–20.  
23. Albores-Gallo L, Mendez-Santos JL, Xochitl-Garcia Luna A, Delgadillo-
Gonzalez Y, Chavez-Flores CI, Martinez OL. Nonsuicidal self-injury in a 
community sample of older children and adolescents of Mexico City. Actas Esp 
Psiquiatr 2014;42:159–68.  
24. Barrocas AL, Hankin BL, Young JF, Abela JRZ. Rates of Nonsuicidal Self-
Injury in Youth: Age, Sex, and Behavioral Methods in a Community Sample. 
Pediatrics 2012;130:39–45.  
25. Manca M, Presaghi F, Cerutti R. Clinical specificity of acute versus chronic 
self-injury: Measurement and evaluation of repetitive non-suicidal self-injury. 
Psychiat Res 2014;215:111–9.  
26. Plener PL, Allroggen M, Kapusta ND, Brähler E, Fegert JM, Groschwitz RC. 
The prevalence of Nonsuicidal Self-Injury (NSSI) in a representative sample of 
the German population. BMC Psychiatry 2016;16:1–7.  
  53 
27. Laye-Gindhu A, Schonert-Reichl KA. Nonsuicidal Self-Harm Among 
Community Adolescents: Understanding the “Whats” and ‘Whys’ of Self-
Harm. J Youth Adolescence 2005;34:447–57.  
28. Nixon MK, Cloutier P, Jansson SM. Nonsuicidal self-harm in youth: a 
population-based survey. CMAJ 2008;178:306–12.  
29. Gratz KL, Conrad SD, Roemer L. Risk factors for deliberate self-harm among 
college students. Am J Orthopsychiatry 2002;72:128–40.  
30. Hilt LM, Nock MK, Lloyd-Richardson EE, Prinstein MJ. Longitudinal Study of 
Nonsuicidal Self-Injury Among Young Adolescents. The Journal of Early 
Adolescence 2008;28:455–69.  
31. Bresin K, Schoenleber M. Gender differences in the prevalence of nonsuicidal 
self-injury: A meta-analysis. Clin Psychol Rev 2015;38:55–64.  
32. In-Albon T, Ruf C, Schmid M. Proposed Diagnostic Criteria for the DSM-5 of 
Nonsuicidal Self-Injury in Female Adolescents: Diagnostic and Clinical 
Correlates. Psychiatry J 2013;2013:1–12.  
33. Fox KR, Franklin JC, Ribeiro JD, Kleiman EM, Bentley KH, Nock MK. Meta-
analysis of risk factors for nonsuicidal self-injury. Clin Psychol Rev 
2015;42:156–67.  
34. Andover MS, Morris BW. Expanding and clarifying the role of emotion 
regulation in nonsuicidal self-injury. Can J Psychiatry 2014;59:569–75.  
35. Glenn CR, Klonsky ED. Prospective Prediction of Nonsuicidal Self-Injury: A 1-
Year Longitudinal Study in Young Adults. Behav Ther 2011;42:751–62.  
36. Stanford S, Jones MP, Hudson JL. Rethinking pathology in adolescent self-
harm: Towards a more complex understanding of risk factors. Journal of 
Adolescence 2017;54:32–41.  
37. Klonsky ED, Moyer A. Childhood sexual abuse and non-suicidal self-injury: 
meta-analysis. Br J Psychiatry 2008;192:166–70.  
38. Liu RT, Scopelliti KM, Pittman SK, Zamora AS. Childhood maltreatment and 
non-suicidal self-injury: a systematic review and meta-analysis. The Lancet 
Psychiatry 2018;5:51–64.  
39. Lereya ST, Copeland WE, Costello EJ, Wolke D. Adult mental health 
consequences of peer bullying and maltreatment in childhood: two cohorts in 
two countries. The Lancet Psychiatry 2015;2:524–31.  
40. Hankin BL, Abela JRZ. Nonsuicidal self-injury in adolescence: Prospective 
rates and risk factors in a 2 ½year longitudinal study. Psychiat Res 
2011;186:65–70.  
 54 
41. Jarvi S, Jackson B, Swenson L, Crawford H. The Impact of Social Contagion on 
Non-Suicidal Self-Injury: A Review of the Literature. Arch Suicide Res 
2013;17:1–19.  
42. Young R, Sproeber N, Groschwitz RC, Preiss M, Plener PL. Why alternative 
teenagers self-harm: exploring the link between non-suicidal self-injury, 
attempted suicide and adolescent identity. BMC Psychiatry 2014;14:133–14.  
43. Bowes L, Carnegie R, Pearson R, Mars B, Biddle L, Maughan B, et al. Risk of 
depression and self-harm in teenagers identifying with goth subculture: a 
longitudinal cohort study. The Lancet Psychiatry 2015;2:793–800.  
44. Batejan KL, Jarvi SM, Swenson LP. Sexual Orientation and Non-Suicidal Self-
Injury: A Meta-Analytic Review. Arch Suicide Res 2014;19:131–50.  
45. Meyer IH. Prejudice, social stress, and mental health in lesbian, gay, and 
bisexual populations: Conceptual issues and research evidence. Psychol Bull 
2003;129:674–97.  
46. Ludäscher P, Greffrath W, Schmahl C, Kleindienst N, Kraus A, Baumgärtner 
U, et al. A cross-sectional investigation of discontinuation of self-injury and 
normalizing pain perception in patients with borderline personality disorder. 
Acta Psychiatrica Scandinavica 2009;120:62–70.  
47. Reitz S, Kluetsch R, Niedtfeld I, Knorz T, Lis S, Paret C, et al. Incision and 
stress regulation in borderline personality disorder: neurobiological 
mechanisms of self-injurious behaviour. Br J Psychiatry 2015;207:165–72.  
48. Schmahl C, Bohus M, Esposito F, Treede R-D, Di Salle F, Greffrath W, et al. 
Neural correlates of antinociception in borderline personality disorder. Arch 
Gen Psychiatry 2006;63:659–67.  
49. Schreiner MW, Klimes-Dougan B, Begnel ED, Cullen KR. Conceptualizing the 
neurobiology of non-suicidal self-injury from the perspective of the Research 
Domain Criteria Project. Neuroscience and Biobehavioral Reviews 
2015;57:381–91.  
50. Taylor PJ, Jomar K, Dhingra K, Forrester R, Shahmalak U, Dickson JM. A 
meta-analysis of the prevalence of different functions of non-suicidal self-
injury. J Affect Disord 2018;227:759–69.  
51. LeDoux JE. Emotion circuits in the brain. Annu. Rev. Neurosci. 2000;23:155–
84.  
52. Plener PL, Bubalo N, Fladung AK, Ludolph AG, Lulé D. Prone to excitement: 
Adolescent females with non-suicidal self-injury (NSSI) show altered cortical 
pattern to emotional and NSS-related material. Psychiatry Research: 
Neuroimaging 2012;203:146–52.  
53. Groschwitz RC, Plener PL, Groen G, Bonenberger M, Abler B. Differential 
neural processing of social exclusion in adolescents with non-suicidal self-
injury: An fMRI study. Psychiatry Research: Neuroimaging 2016;255:43–9.  
  55 
54. Osuch E, Ford K, Wrath A, Bartha R, Neufeld R. Functional MRI of pain 
application in youth who engaged in repetitive non-suicidal self-injury vs. 
psychiatric controls. Psychiatry Research: Neuroimaging 2014;223:104–12.  
55. Stanley B, Sher L, Wilson S, Ekman R, Huang Y-Y, Mann JJ. Non-suicidal self-
injurious behavior, endogenous opioids and monoamine neurotransmitters. J 
Affect Disord 2010;124:134–40.  
56. Klonsky ED. The functions of self-injury in young adults who cut themselves: 
Clarifying the evidence for affect-regulation. Psychiat Res 2009;166:260–8.  
57. Reichl C, Heyer A, Brunner R, Parzer P, Völker JM, Resch F, et al. 
Hypothalamic-pituitary-adrenal axis, childhood adversity and adolescent 
nonsuicidal self-injury. Psychoneuroendocrinology 2016;74:203–11.  
58. Beauchaine TP, Crowell SE, Hsiao RC. Post-dexamethasone cortisol, self-
inflicted injury, and suicidal ideation among depressed adolescent girls. J 
Abnorm Child Psychol 2015;43:619–32.  
59. Kaess M, Hille M, Parzer P, Maser-Gluth C, Resch F, Brunner R. Alterations in 
the neuroendocrinological stress response to acute psychosocial stress in 
adolescents engaging in nonsuicidal self-injury. Psychoneuroendocrinology 
2012;37:157–61.  
60. Turecki G. The molecular bases of the suicidal brain. Nature Publishing Group 
2014;15:802–16.  
61. Mann JJ, Arango VA, Avenevoli S, Brent DA, Champagne FA, Clayton P, et al. 
Candidate Endophenotypes for Genetic Studies of Suicidal Behavior. BPS 
2009;65:556–63.  
62. Hankin BL, Barrocas AL, Young JF, Haberstick B, Smolen A. 5-
HTTLPR×interpersonal stress interaction and nonsuicidal self-injury in 
general community sample of youth. Psychiat Res 2015;225:609–12.  
63. Plener PL, Schumacher TS, Munz LM, Groschwitz RC. The longitudinal course 
of non-suicidal self-injury and deliberate self-harm: a systematic review of the 
literature. Borderline Personal Disord Emot Dysregul 2015;2:2.  
64. Nakar O, Brunner R, Schilling O, Chanen A, Fischer G, Parzer P, et al. 
Developmental trajectories of self-injurious behavior, suicidal behavior and 
substance misuse and their association with adolescent borderline personality 
pathology. J Affect Disord 2016;197:231–8.  
65. Mars B, Heron J, Crane C, Hawton K, Lewis G, Macleod J, et al. Clinical and 
social outcomes of adolescent self harm: population based birth cohort study. 
BMJ 2014;349:g5954–4.  
66. Borschmann R, Becker D, Coffey C, Spry E, Moreno-Betancur M, Moran P, et 
al. 20-year outcomes in adolescents who self-harm: a population-based cohort 
study. The Lancet Child & Adolescent Health 2017;1:195–202.  
 56 
67. Asarnow JR, Porta G, Spirito A, Emslie G, Clarke G, Wagner KD, et al. Suicide 
attempts and nonsuicidal self-injury in the treatment of resistant depression in 
adolescents: findings from the TORDIA study. J Am Acad Child Adolesc 
Psychiatry 2011;50:772–81.  
68. Guan K, Fox KR, Prinstein MJ. Nonsuicidal self-injury as a time-invariant 
predictor of adolescent suicide ideation and attempts in a diverse community 
sample. J Consult Psychol 2012;80:842–9.  
69. Wilkinson P, Kelvin R, Roberts C, Dubicka B, Goodyer I. Clinical and 
psychosocial predictors of suicide attempts and nonsuicidal self-injury in the 
Adolescent Depression Antidepressants and Psychotherapy Trial (ADAPT). 
Am J Psychiatry 2011;168:495–501.  
70. Wilkinson B. Current trends in remediating adolescent self-injury: an 
integrative review. J Sch Nurs 2011;27:120–8.  
71. Chapman AL, Gratz KL, Brown MZ. Solving the puzzle of deliberate self-harm: 
The experiential avoidance model. Behav Res Ther 2006;44:371–94.  
72. Linehan M. Cognitive-behavioral treatment of borderline personality disorder. 
New York: Guilford press; 1993.  
73. Nock MK. Why do People Hurt Themselves? New Insights Into the Nature and 
Functions of Self-Injury. Curr Dir Psychol Sci 2009;18:78–83.  
74. Saunders KEA, Hawton K, Fortune S, Farrell S. Attitudes and knowledge of 
clinical staff regarding people who self-harm: A systematic review. J Affect 
Disord 2012;139:205–16.  
75. Taylor TL, Hawton K, Fortune S, Kapur N. Attitudes towards clinical services 
among people who self-harm: systematic review. Br J Psychiatry 2009;194:104–
10.  
76. Brunner R, Parzer P, Haffner J, Steen R, Roos J, Klett M, et al. Prevalence and 
psychological correlates of occasional and repetitive deliberate self-harm in 
adolescents. Arch Pediatr Adolesc Med 2007;161:641–9.  
77. Fortune S, Sinclair J, Hawton K. Help-seeking before and after episodes of self-
harm: a descriptive study in school pupils in England. BMC Public Health 
2008;8:369.  
78. Deliberto TL, Nock MK. An exploratory study of correlates, onset, and offset of 
non-suicidal self-injury. Arch Suicide Res 2008;12:219–31.  
79. Armiento JS, Hamza CA, Willoughby T. An Examination of Disclosure of 
Nonsuicidal Self-injury among University Students. J. Community Appl. Soc. 
Psychol. 2014;24:518–33.  
80. Lloyd-Richardson EE, Perrine N, Dierker L, Kelley ML. Characteristics and 
functions of non-suicidal self-injury in a community sample of adolescents. 
Psychol Med 2007;37:1183–92.  
  57 
81. SBU. Self-harm: patients’ experiences and perceptions of professional care and 
support. Stockholm: Swedish Agency for Health Technology Assessment and 
Assessment of Social Services (SBU); 2015. SBU report no 2015-04 (in 
Swedish).  
82. Gross JJ. Emotion Regulation: Current Status and Future Prospects. 
Psychological Inquiry 2015;26:1–26.  
83. Thompson RA. Emotion regulation: a theme in search of definition. Monogr 
Soc Res Child Dev 1994;59:25–52.  
84. Garner PW, Spears FM. Emotion Regulation in Low‐income Preschoolers. 
Social Development 2000;9:246–64.  
85. Zeman J, Garber J. Display rules for anger, sadness, and pain: it depends on 
who is watching. Child Dev 1996;67:957–73.  
86. Cole PM, Michel MK, Teti LO. The development of emotion regulation and 
dysregulation: a clinical perspective. Monogr Soc Res Child Dev 1994;59:73–
100.  
87. Gratz KL. Targeting emotion dysregulation in the treatment of self-injury. J. 
Clin. Psychol. 2007;63:1091–103.  
88. Thompson RA, Calkins SD. The double-edged sword: Emotional regulation for 
children at risk. Dev. Psychopathol. 1996;8:163–82.  
89. Izard CE, Ackerman BP. Motivational, organizational, and regulatory functions 
of discrete emotions. In: Lewis M, Haviland-Jones JM, editors. Handbook of 
emotions. New York: Guildford Press; 2000. pages 253–64. 
90. Sheppes G, Suri G, Gross JJ. Emotion Regulation and Psychopathology. Annu 
Rev Clin Psychol 2015;11:379–405.  
91. Bagby RM, Taylor GJ, Parker J. The twenty-item Toronto Alexithymia Scale—
II. Convergent, discriminant, and concurrent validity. Journal of 
psychosomatic research 1994;38:33–40.  
92. Gross JJ, John OP. Individual differences in two emotion regulation processes: 
Implications for affect, relationships, and well-being. Journal of Personality and 
Social Psychology 2003;85:348–62.  
93. Hofmann SG, Kashdan TB. The Affective Style Questionnaire: Development 
and Psychometric Properties. 2009;32:255–63. Available from: 
http://link.springer.com/10.1007/s10862-009-9142-4 
94. Simons JS, Gaher RM. The Distress Tolerance Scale: Development and 
Validation of a Self-Report Measure. Motiv Emot 2005;29:83–102.  
95. Taylor CT, Laposa JM, Alden LE. Is avoidant personality disorder more than 
just social avoidance? J. Pers. Disord. 2004;18:571–94.  
 58 
96. Gratz KL, Roemer L. Multidimensional Assessment of Emotion Regulation and 
Dysregulation: Development, Factor Structure, and Initial Validation of the 
Difficulties in Emotion Regulation Scale. J Psychopathol Behav Assess 
2004;26:41–54.  
97. Glenn CR, Franklin JC, Nock MK. Evidence-Based Psychosocial Treatments 
for Self-Injurious Thoughts and Behaviors in Youth. J Clin Child Adolesc 
Psychol 2014;44:1–29.  
98. Hawton K, Witt KG, Taylor Salisbury TL, Arensman E, Gunnell D, Townsend 
E, et al. Interventions for self-harm in children and adolescents. Cochrane 
Database Syst Rev 2015;:CD012013.  
99. Ougrin D, Tranah T, Stahl D, Moran P, Asarnow JR. Therapeutic interventions 
for suicide attempts and self-harm in adolescents: systematic review and meta-
analysis. J Am Acad Child Adolesc Psychiatry 2015;54:97–107.e2.  
100. Turner BJ, Austin SB, Chapman AL. Treating nonsuicidal self-injury: a 
systematic review of psychological and pharmacological interventions. Can J 
Psychiatry 2014;59:576–85.  
101. Chambless DL, Hollon SD. Defining empirically supported therapies. J Consult 
Psychol 1998;66:7–18.  
102. Hawton K, Witt KG, Taylor Salisbury TL, Arensman E, Gunnell D, Hazell P, et 
al. Pharmacological interventions for self-harm in adults. Cochrane Database 
of Systematic Reviews 2015;14:361–6.  
103. National Collaborating Centre for Mental Health (UK). Self-Harm: Longer-
Term Management. 2012; 
104. Washburn JJ, Richardt SL, Styer DM, Gebhardt M, Juzwin KR, Yourek A, et al. 
Psychotherapeutic approaches to non-suicidal self-injury in adolescents. Child 
Adolesc Psychiatry Ment Health 2012;6:14.  
105. Mehlum L, Tørmoen AJ, Ramberg M, Haga E, Diep LM, Laberg S, et al. 
Dialectical behavior therapy for adolescents with repeated suicidal and self-
harming behavior: a randomized trial. J Am Acad Child Adolesc Psychiatry 
2014;53:1082–91.  
106. Rossouw TI, Fonagy P. Mentalization-based treatment for self-harm in 
adolescents: a randomized controlled trial. J Am Acad Child Adolesc 
Psychiatry 2012;51:1304–1313.e3.  
107. Gratz KL, Gunderson JG. Preliminary data on an acceptance-based emotion 
regulation group intervention for deliberate self-harm among women with 
borderline personality disorder. Behav Ther 2006;37:25–35.  
108. Evans K, Tyrer P, Catalan J, Schmidt U, Davidson K, Dent J, et al. Manual-
assisted cognitive-behaviour therapy  (MACT): a randomized controlled trial 
of a brief  intervention with bibliotherapy in the treatment of  recurrent 
deliberate self-harm. Psychol Med 1999;29:19–25.  
  59 
109. Woody GE, McLellan AT, Luborsky L, O'Brien CP. Sociopathy and 
psychotherapy outcome. Arch Gen Psychiatry 1985;42:1081–6.  
110. Pistorello J, Fruzzetti AE, MacLane C, Gallop R, Iverson KM. Dialectical 
behavior therapy (DBT) applied to college students: A randomized clinical 
trial. J Consult Psychol 2012;80:982–94.  
111. Verheul R, Van den Bosch L, Koeter M, De Ridder M, Stijnen T, Van den Brink 
W. Dialectical behaviour therapy for women with borderline personality 
disorder - 12-month, randomised clinical trial in The Netherlands. Br J 
Psychiatry 2003;182:135–40.  
112. Linehan MM, Comtois KA, Murray AM, Brown MZ, Gallop RJ, Heard HL, et 
al. Two-year randomized controlled trial and follow-up of dialectical behavior 
therapy vs therapy by experts for suicidal behaviors and borderline personality 
disorder. Arch Gen Psychiatry 2006;63:757–66.  
113. McMain SF, Links PS, Gnam WH, Guimond T, Cardish RJ, Korman L, et al. A 
Randomized Trial of Dialectical Behavior Therapy Versus General Psychiatric 
Management for Borderline Personality Disorder. American Journal of 
Psychiatry 2009;166:1365–74.  
114. Zanarini MC. Psychotherapy of borderline personality disorder. Acta 
Psychiatrica Scandinavica 2009;120:373–7.  
115. Gratz KL, Tull MT, Levy R. Randomized controlled trial and uncontrolled 9-
month follow-up of an adjunctive emotion regulation group therapy for 
deliberate self-harm among women with borderline personality disorder. 
Psychol Med 2014;44:2099–112.  
116. Gratz KL, Tull MT. Extending research on the utility of an adjunctive emotion 
regulation group therapy for deliberate self-harm among women with 
borderline personality pathology. Personal Disord 2011;2:316–26.  
117. Kazdin AE. Mediators and Mechanisms of Change in Psychotherapy Research. 
Annu Rev Clin Psychol 2007;3:1–27.  
118. Holmes EA, Ghaderi A, Harmer CJ, Ramchandani PG, Cuijpers P, Morrison 
AP, et al. The Lancet Psychiatry Commission on psychological treatments 
research in tomorrow's science. The Lancet Psychiatry 2018;5:237–86.  
119. Kazdin AE. Understanding how and why psychotherapy leads to change. 
Psychother Res 2009;19:418–28.  
120. Gratz KL, Levy R, Tull MT. Emotion Regulation as a Mechanism of Change in 
an Acceptance-Based Emotion Regulation Group Therapy for Deliberate Self-
Harm Among Women With Borderline Personality Pathology. J Cogn 
Psychother 2012;26:365–80.  
121. Gratz KL, Bardeen JR, Levy R, Dixon-Gordon KL, Tull MT. Mechanisms of 
change in an emotion regulation group therapy for deliberate self-harm among 
women with borderline personality disorder. Behav Res Ther 2015;65:29–35.  
 60 
122. Cottrell DJ, Wright-Hughes A, Collinson M, Boston P, Eisler I, Fortune S, et al. 
Effectiveness of systemic family therapy versus treatment as usual for young 
people after self-harm: a pragmatic, phase 3, multicentre, randomised 
controlled trial. The Lancet Psychiatry 2018;5:203–16.  
123. Andersson G. Internet-Delivered Psychological Treatments. Annu Rev Clin 
Psychol 2016;12:157–79.  
124. Vigerland S, Lenhard F, Bonnert M, Lalouni M, Hedman E, Ahlen J, et al. 
Internet-delivered cognitive behavior therapy for children and adolescents: A 
systematic review and meta-analysis. Clin Psychol Rev 2016;50:1–10.  
125. Carlbring P, Andersson G, Cuijpers P, Riper H, Hedman-Lagerlöf E. Internet-
based vs. face-to-face cognitive behavior therapy for psychiatric and somatic 
disorders: an updated systematic review and meta-analysis. Cogn Behav Ther 
2017;47:1–21.  
126. Berger M, Wagner TH, Baker LC. Internet use and stigmatized illness. Soc Sci 
Med 2005;61:1821–7.  
127. Frost M, Casey L. Who Seeks Help Online for Self-Injury? Arch Suicide Res 
2016;20:69–79.  
128. Hetrick SE, Yuen HP, Bailey E, Cox GR, Templer K, Rice SM, et al. Internet-
based cognitive behavioural therapy for young people with suicide-related 
behaviour (Reframe-IT): a randomised controlled trial. Evid Based Ment 
Health 2017;20:76–82.  
129. van Spijker BAJ, van Straten A, Kerkhof AJFM. Effectiveness of Online Self-
Help for Suicidal Thoughts: Results of a Randomised Controlled Trial. PLoS 
ONE 2014;9:e90118.  
130. Hesser H. Modeling individual differences in randomized experiments using 
growth models: Recommendations for design, statistical analysis and reporting 
of results of internet interventions. INVENT 2015;2:110–20.  
131. Rosseel Y. lavaan: An R Package for Structural Equation Modeling. Journal of 
Statistical Software 2012;48.  
132. Schermelleh-Engel K, Moosbrugger H. Evaluating the Fit of Structural 
Equation Models: Tests of Significance and Descriptive Goodness-of-Fit 
Measures. Methods of Psychological Research Online 2003;8:23–74.  
133. Green JM, Wood AJ, Kerfoot MJ, Trainor G, Roberts C, Rothwell J, et al. 
Group therapy for adolescents with repeated self harm: randomised controlled 
trial with economic evaluation. BMJ 2011;342:d682–2.  
134. Hazell PL, Martin G, Mcgill K, Kay T, Wood AJ, Trainor G, et al. Group 
Therapy for Repeated Deliberate Self-Harm in Adolescents: Failure of 
Replication of a Randomized Trial. J Am Acad Child Adolesc Psychiatry 
48:662–70.  
  61 
135. Casey BJ. Beyond Simple Models of Self-Control to Circuit-Based Accounts of 
Adolescent Behavior. Annu Rev Psychol 2015;66:295–319.  
136. Brent DA, McMakin DL, Kennard BD, Goldstein TR, Mayes TL, Douaihy AB. 
Protecting adolescents from self-harm: a critical review of intervention studies. 
J Am Acad Child Adolesc Psychiatry 2013;52:1260–71.  
137. Bonnert M, Olén O, Lalouni M, Benninga MA, Bottai M, Engelbrektsson J, et 
al. Internet-Delivered Cognitive Behavior Therapy for Adolescents With 
Irritable Bowel Syndrome: A Randomized Controlled Trial. Am. J. 
Gastroenterol. 2016;112:152–62.  
138. Jolstedt M, Ljótsson B, Fredlander S, Tedgård T, Hallberg A, Ekeljung A, et al. 
Implementation of internet-delivered CBT for children with anxiety disorders 
in a rural area: A feasibility trial. Internet Interventions 2017; 
139. Lalouni M, Ljótsson B, Bonnert M, Hedman-Lagerlöf E, Högström J, Serlachius 
E, et al. Internet-Delivered Cognitive Behavioral Therapy for Children With 
Pain-Related Functional Gastrointestinal Disorders: Feasibility Study. JMIR 
Ment Health 2017;4:e32–21.  
140. Lenhard F, Andersson E, Mataix-Cols D, Rück C, Vigerland S, Högström J, et 
al. Therapist-Guided, Internet-Delivered Cognitive-Behavioral Therapy for 
Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled 
Trial. J Am Acad Child Adolesc Psychiatry 2017;56:10–2.  
141. Vigerland S, Ljótsson B, Thulin U, Öst L-G, Andersson G, Serlachius E. 
Internet-delivered cognitive behavioural therapy for children with anxiety 
disorders: A randomised controlled trial. Behav Res Ther 2016;76:47–56.  
142. LeDoux JE, Moscarello J, Sears R, Campese V. The birth, death and 
resurrection of avoidance: a reconceptualization of a troubled paradigm. 
Molecular Psychiatry 2016;22:24–36.  
143. Foa EB, Kozak MJ. Emotional processing of fear: exposure to corrective 
information. Psychol Bull 1986;99:20–35.  
144. Trull TJ, Ebner-Priemer U. The Role of Ambulatory Assessment in 
Psychological Science. Curr Dir Psychol Sci 2014;23:466–70.  
145. Hatcher RL, Gillaspy JA. Development and validation of a revised short version 
of the working alliance inventory. Psychotherapy Research 2006;16:12–25.  
146. Cook SH, Clancy C, Sanderson S. Self-harm and suicide: care, interventions 
and policy. Nurs Stand 2004;18:43–52–quiz54.  
147. Shaw DG, Sandy PT. Mental health nurses' attitudes toward self-harm: 
Curricular implications. Health SA Gesondheid 2016;21:406–14.  
148. Lindgren B-M, Öster I, Åström S, Hällgren Graneheim U. “They don't 
understand…you cut yourself in order to live.” Interpretative repertoires 
jointly constructing interactions between adult women who self-harm and 
 62 
professional caregivers. International Journal of Qualitative Studies on Health 
and Well-being 2011;6:7254–13.  
149. Nock MK. Self-Injury. Annu Rev Clin Psychol 2010;6:339–63.  
150. SBU. School based programs to prevent self-harm including suicide attempts. 
Stockholm: Swedish Agency for Health Technology Assessment and 
Assessment of Social Services (SBU); 2015. SBU report no 241 (in Swedish). 
151. Ougrin D, Asarnow JR. Comment The end of family therapy for self-harm, or a 
new beginning? The Lancet Psychiatry 2018;5:188–9.  
152. Andover MS, Schatten HT, Morris BW, Holman CS, Miller IW. An 
intervention for nonsuicidal self-injury in young adults: A pilot randomized 
controlled trial. J Consult Psychol 2017;85:620–31.  
153. Bentley KH, Nock MK, Sauer-Zavala S, Gorman BS, Barlow DH. A functional 
analysis of two transdiagnostic, emotion-focused interventions on nonsuicidal 
self-injury. J Consult Psychol 2017;85:632–46.  
154. Taylor LMW, Oldershaw A, Richards C, Davidson K, Schmidt U, Simic M. 
Development and Pilot Evaluation of a Manualized Cognitive-Behavioural 
Treatment Package for Adolescent Self-Harm. Behav. Cogn. Psychother. 
2011;39:619–25.  
155. Simonsson O, Stensils J. Is Internet delivered Emotion Regulation Individual 
Therapy a promising treatment for adolescents with Non-Suicidal Self-Injury? 
[master's thesis]. Karolinska Institutet. Stockholm: 2017.  
156. Gelman A, Stern H. The Difference Between “Significant” and ‘Not Significant’ 
is not Itself Statistically Significant. The American Statistician 2006;60:328–31.  
157. Moran P, Coffey C, Romaniuk H, Olsson C, Borschmann R, Carlin JB, et al. 
The natural history of self-harm from adolescence to young adulthood: a 
population-based cohort study. Lancet 2012;379:236–43.  
158. Bohus M, Limberger MF, Frank U, Sender I, Gratwohl T, Stieglitz RD. 
[Development of the Borderline Symptom List]. Psychother Psychosom Med 
Psychol 2001;51:201–11.  
159. Kazdin AE. Single-case research designs : methods for clinical and applied 
settings. 2nd ed. New York: Oxford University Press; 2011.  
160. Brunner R, Kaess M, Parzer P, Fischer G, Carli V, Hoven CW, et al. Life-time 
prevalence and psychosocial correlates of adolescent direct self-injurious 
behavior: A comparative study of findings in 11 European countries. J Child 
Psychol Psychiatr 2014;55:337–48.  
161. Lee JY, Harvey AG. Memory for therapy in bipolar disorder and comorbid 
insomnia. J Consult Psychol 2015;83:92–102.  
  63 
162. Waller G, Turner H. Therapist drift redux: Why well-meaning clinicians fail to 
deliver evidence-based therapy, and how to get back on track. Behav Res Ther 
2016;77:129–37.  
163. Miguel FK, Giromini L, Colombarolli MS, Zuanazzi AC, Zennaro A. A 
Brazilian Investigation of the 36- and 16-Item Difficulties in Emotion 
Regulation Scales. J. Clin. Psychol. 2016;:1–14.  
164. Yiğit İ, Yiğit MG. Psychometric Properties of Turkish Version of Difficulties in 
Emotion Regulation Scale-Brief Form (DERS-16). Curr Psychol 2017;30:1–9.  
165. Gratz KL. Measurement of Deliberate Self-Harm: Preliminary Data on the 
Deliberate Self-Harm Inventory. J Psychopathol Behav Assess 2001;23:253–63.  
 
